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INTROIXJCTIOO 
In view of the present problems of family planning and population 
control, the investigation of methods of fertility control assumes 
great importance. During the past several decades, the knowledge and 
practice of the prevention of disease has advanced rapidly resulting in 
marked decreases in mortality rates all over the V«)rld. In certain 
small countries, most notably those in the far east, overpopulation has 
become a serious threat to both the economic and physical well-being of 
the people. 
An excellent example of the effect of the control of disease in 
reducing the death rate is the virtual eradication of malaria in Ceylon 
within a period of two to three years. In 1940, the population of Cey-
lon was 6,ooo,ooo; the birth rate, 36 per thousand; and the death rate, 
21 per thousand. As control measures were taken against malaria, the 
death rate dropped from 21.3 in the years between 1943 and 1946 to 13.4 
between 1947 and 1949. During 1943 to 1946, the birth rate was 38.2, 
and during the following three years, 39.9. Thus, because of the eradi-
cation of malaria, the rate of natural increase rose from 16. 9 bet-ween 
1943 and 1946 to 20.5 between 1947 and 1949. It can be calculated that, 
if this trend were to continue, the population of Ceylon would be double 
in 27 years. (1,2). 
Another very strildng example is that of Puerto Rico. Prior to 
its accession by the United States in 1898, the birth rate was over 40 
and the death rate was between 25 and 30. There was subsequently a 
slow decline in death rate so that in 1932 it was 22. However, at this 
time, the United States instituted a relief program Which resulted in a 
drop in the death rate. By 1940, it had reached 18.4, and by 1948, 
12.0. During these 50 years, the birth rate remained at 40. In spite 
of emigration to the United States, the population grew from 1,544,000 
in 1930 to 2,205,000 in 1950, an increase of 43 percent. The present 
excess of births over deaths is about 62,000 per year, and at this 
natural rate of increase the population of Puerto Rico could double in 
about 25 years. (2). 
These are but two outstanding examples of a general, worldwide 
trend. Thus, the population of India has risen from 256 millions in 
1872 to 294 millions in 1921 and 429 millions in 1951. The Phillipines 
have grown from 7.6 millions in 1903 to about 19.2 millions in 1948, and 
Java, from 28 millions in 1900 to 49 millions in 1950. (1). The Popu-
lation Problem Council which was established by the Cabinet of Japan in 
1949 predicted that according to present trends, within the next 20 years 
the population of Japan will grow from its present level of 80.2 to 100 
millions, an increase of 25 percent. (2). Considering the world as a 
whole, during the 300 year period from 1650 when the life e:x:pe ctancy 
was approximately 33 years to 1949 when the life expectancy was 68 years, 
the population has increased from 545 millions to 2,378 millions. 
Furthermore, if the population increase continues as it has for the 
past 30 years at an average rate of 0.9 percent per year, at the end of 
the next 300 year period the world population will be 35.4 billion. (2). 
The presentation of such statistics poses the question of whether 
the advantages of disease control now available to only a minority of 
the world's people can be made available to all so that the advantages 
made possible by the control of mortality are not nullified by rapid 
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population increases. The actual problem arises when it is realized 
that, in order to prevent such nullifying effects, existing and poten-
tial natural resources must provide for the maintenance of such popu-
lation increases. 
Opinions exist, however, that the population problem is not, in 
actuality, important. The reasoning is that advances in agricultural. 
and industrial science potentiate exploitation of many heretofore un-
utilized resources which m~ well provide for the maintenance of in-
creased populations. An answer to this, perhaps a little too emotional, 
but nevertheless pointed, has been given by Robert c. Cook, editor of 
the Journal of Heredity: 
11My impatience with pundits of science who beg the 
population question by promising miracles of loaves, 
fishes, and/or algae does not imply that I under-
estimate the contribution that science might, and 
can, make to a solution of the problem. My objec-
tion stems from a fervent conviction that when 
science pretends to ape the vaudeville magician, it 
ceases to be science. Ability to produce food does 
not free human beings from the urgent responsibility 
of considering the optimum population of the world, 
and preventing hopeless multiplication beyond this 
optimum -------------------. 11 (3). 
Assuming the existence of a population problem, two solutions are 
possible: (a) to speed up production capacity until it attains a rate 
. 
of grovrth well beyond that of t he population, and (b) to reduce the 
rate at which people reproduce. Since neither solution alone is prac-
tical, the ideal situation would be one in which both of these changes 
are effected simultaneously. 
vVhile the first solution must be left, for the most part, in the 
hands of the economists, industrialists, agriculturalists, and chemists, 
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the biologists must necessarily take part in the alternate. It is the 
obligation of the biologist to cooperate with population planning or-
ganizations and clinics in the investigation of methods of fertility 
control. 
In order for such methods to be practical and widely accepted for 
use, the materials involved must meet certain requirements: (a) they 
must be inexpensive and easy to produce; (b) they must be easy to use; 
(c) they must be aesthetically acceptable; (d) they must be completely 
non-toxic; (e) they must be completely reliable. Presently used con-
traceptive methods do not meet these requirements, since the most re-
liable ones are expensive and difficult to use. These means of fertility 
control may be called "mechanical" methods. The term "mechanical" can 
properly be used since the most efficient of these methods consist es-
sentially of various means of preventing viable spermatozoa from entering 
the os cervix. Thus, only one of the many phases of the reproductive 
process is used as a point for the introduction of contraceptive mea-
sures. 
The more recent investigations of fertility control have been 
largely concerned with possible "physiological" methods. These methods 
are based upon the fact that the reproductive process consists of a 
natural sequence of events each of which depend on delicate hormone, 
enzyme, dietary and other physiological balances for successful com-
pletion, and that slight alterations in these balances during any of a 
number of the natural events may prevent the reproductive process from 
going to completion. While further research on mechanical methods is 
more or less limited to the improvement of presently used devises, the 
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physiological approach offers a wide variety of new possibilities for 
investigation. 
In order to analyze critically the possible lines of investigation 
of the physiological control of fertility, it is necessary to review 
briefly recent research in connection with the phases of the process of 
repro due tion. 
For the purposes of this review, the hormonal activity which occurs 
before fertilization takes place maybe considered as the first phase of 
reproduction. The anterior pituitary gland is responsive to nervous and 
hormonal stimuli, and secretes, anong other substances, gonadotrophins 
of Which there are at least three, FSH, the follicle-stimulating hormone, 
LH, the luteinizing hormone, and LTH, the luteotrophic hormone. FSH 
stimulates follicle growth in the female and spermatogenesis in the male. 
I.H stimulates ovulation, while LTH has a trophic action on the corpora 
lutea. Early in the estrous cycle, FSH is secreted resulting in a rapid 
growth of the follicles. As this occurs, the secretion of estrogens 
from the ovary gradually increases and suppresses the secretion of FSH, 
The estrogen, on the other hand, stimulates LH release and ovulation 
occurs. Once the ovum is released and the corpus lutem is formed, pro-
gesterone is secreted suppressing LH and preventing further ovulations 
i'rom occurring until just before the beginning of the next cycle when 
the progesterone level drops sharply. Thus, ovulation and spermato-
genesis are controlled by gonadotrophins, which, in turn, are influenced 
by hormonal secretions of the ovaries and testes. 
This pattern of hormone activity lends itself well to research on 
fertility control. Moore and Price (4), Meyer~ al (5), and Finnerty 
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and Meyer (6) have shown that estrogens reduce tl:'e gonadotrophin content 
of the anterior pituitary gland. Dempsey (7), Makepeace et al (8), and 
--
Astwood and Fevold (9) have presented evidence that progesterone in-
hibits the secretion of L.H. Progesterone has further been found to be 
an active inhibitor of ovulation, presumably because of its anti-gonado-
trophic activity (10,11,12,13,14). Considering the male, Ludwig, (15) 
and Heckel et al (16,17), have demonstrated that low doses of teste-
sterone suppress pituitary secretion of gonadotrophins with accompanying 
abolition of spenn formation. Hormones from other sources have also been 
shown to influence the estrous cycle. Inhibition of estrus by prolactin 
has been reported by Dresel (18) and Lahr and Riddle (19). Since ante-
rior pituitary hormones are protein in character, gonadotrophins may be 
used as antigens to produce antibodies in the serum. When such serum is 
injected, gonadotrophin secretion is inhibited (20,21,22). Certain 
dietary deficiencies such as arginine and possibly vitamin ~2 have been 
found to affect spermatogenesis adversely (23,24). Certain special 
agents such as nitrofuran, furacin, md furadoxyl inhibit spermatogenesis 
(25,26,27). Extracts of the desert plant, Lithospermum ruderale, have 
been reported to inhibit ovulation and gonadotrophic function (28,29,30, 
31,32,33,34,35,36). Henshaw (37) has, moreover, listed about 70 herb 
preparations some of which may, upon investigation, prove to be inhibitors 
of ovulation and spermatogenesis. Thus, at this single reproductive phase 
of gamete production, there are many possibilities for the investigation 
of methods of fertility control. 
As spermatozoa are produced, they accumulate in the epididymis and 
become motile only upon ejaculation when they are expelled with fluids 
6 
.from the prostate and other glands. The pH, viscosity, and enzyme, 
hormone and nutrient content of the seminal fluid are critical factors 
in determining the viability of spermatozoa, .A1 though much work has 
I 
been done on the metabolism of spermatozoa, little or none has been 
done on the possibilities of the in~ control of spermatozoan viabi-
lity (38). 
In order for fertilization to occur, viable spermatozoa must pass 
through the cervix and enter the uterus. However, in order for sperma,.. 
tozoa to remain viable, the environments afforded by the vagina, cervix, 
and uterus are important. The pH viscosity, and nutrient, hormone, 
enzyme, and substrate materials are critical. Although a certain amount 
of investigation has been done, mo re information is needed concerning 
the roles played by these fluids in the metabolism of spermatozoa (39, 
40,41,42,43,44,45,46,47). Nevertheless, this phase presents still 
another point for the investigation of physiological methods of ferti-
lity control. 
If fertilization is to take place, the spermatozoan must penetrate 
the ovum. Upon ovulation, the ovum is enclosed by follicle cells in a 
mucous clot. Me Clean and Rowlands (48, Fekete and Duran-Reynals (49), 
and Leonard and Kurzok (50) have made the important discovery that 
hyaluronidase, an enzyme prepared from testis extracts and found in 
high concentrations in semen, has the ability to disperse the follicle 
cells. Since the actual role played by hyaluronidase in fertilization 
is still obscure, further investigation is necessary (51,52,53). 
Furthermore, other enzymes are undoubtedly CP ncerned in the fertiliza,.. 
tion process. Much information is ~11 needed about the process of 
penetration of the sperm into the ovum. Information is also needed 
about the chemical and physical aspects of cell division occurring 
after the successful penetration of the spermatozoan. Little is 
actually known about the mechanism of polar body formation, pronuclear 
formation and fusion, and subsequent nuclear divisions. Further in-
vestigation of these mechanisms may reveal much that could be of use 
to the investigator of fertility control. Once an ovum is fertilized, 
it must pass through the Fallopian tube into the uterus in order to 
become implanted. This process generally ta.kBs from three to four 
days, and it is during this period that progesterone stimulates the 
proliferation of the uteri ne endometrium in preparation for the im-
plantation of the ovum. Thus, a sufficient interval between the times 
of ovulation and implantation is necessary for the preparation of the 
uterus. Burdick and Whitney (.54) and Burdick~ al (.5.5,.56) have demon-
strated that both estrogens and testosterone accelerate passage of the 
ovum through the tubes resulting in degeneration of the ovum in the 
uterus. Parkes et 2! (.57) have found that estrogens inhibit implan-
tation because they antagonize progesterone. Another possibility for 
investigation is the inhibiting effect of pregnanediol on progesterone 
(.58). Evans and Burr (.59) have r eported that successful reproduction 
is dependent on the fat soluble vitamin E, and Barrie (60) has shown 
that such a deficiency is responsible for the interruption of gestation, 
after implantation has occurred. Fetal death, prolonged gestation, and 
difficult parturition have been reported to occur in vitamin A deficient 
rats (61,62). Hertz and Tullner (63), Thiersch and Philips (64), and 
Thiersch (6.5) have found that tissue growth and embryonic development 
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is quantitatively dependent on folic acid and that anti-folic acid 
agents such as aminopterin interfere with such growth. Nelson et al 
--
(66), have demonstrated that fetal resorption can occur in pyridoxine-
deficient rats. Although the exact mechanisms involved in many of the 
above findings are unknown, further investigation may reveal still 
other possibilities for the application of fertility control pr ocedures. 
Thus, there are many phases at which the reproductive process may 
be interrupted by the mere shifting of delicate physiological balances. 
However, in order to avoid the initiation of as many of the physio-
logical activities involved i n reproduction as possible, the interruption 
of the progress of pregnancy at an early stage, preferably that of gamete 
production or fertilization would be desirable. Since, as yet, little 
is known about the mechanisms involved in fertilization, the investi-
gation of its physiological control is severely hampered. On the other 
hand, there is sufficient information available about the hormonal 
interrelationships occurring during gamete production to warrant a 
complete survey of possible methods of hormonal fertility control. Al-
though the possibilities of hormonal control of spermatogenesis are 
evident, the many orderly timed r elationships between estrogens, pro-
gesterone, and gonadotrophins occurring during ovum production make the 
female a more desirable experimental subject for the alteration of 
physiological balances. Furthermore, while immune reactions, di e t ary 
restrictions, and the administration of special agents are either im-
practical or more liable to produce various side effects, the hormonal 
inhibition of ovulation could provide a method that would interrupt the 
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reproductive process at a conveni ent time with agents that are 
naturally present i n the body. 
In reference to the previously stated requirements for an ideal 
contraceptive, an inexpensive, synthetic, orally effective inhibitor 
of gonadotrophins would be t he most desirable agent for the hormonal 
cont rol of ferti lity. At the present time, because of its natural 
ovulation-inhibiting action during the normal cycle and during preg-
nancy, progesterone is the most promising anti-gonadotrophic agent. 
Although the ovulation-inhibiting properties of progesterone and of 
certain synthetic derivatives have been •rell established in rabbits, 
no systematic investigation of methods of administration, dosages, and 
side effects has been made in spontaneously ovulating animals (67). 
Therefore, it is the purpose of this investigation to determine the 
ovulation-inhibiting effectiveness, and, where possible, t he side ef-
fects of various dosages and types of administration of progesterone 
and certain related compounds in the rat. 
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LITERATURE REVIEW 
The discovery of the endocrine function of the corpus luteum. 
Long before experimental evidence became available, there were 
many hypotheses regarding the function of the corpus luteum. In 1897, 
Beard (68) first suggested that the corpora luten constitute an "organ 
of pregnancy'' which may exert an inhibiting influence on ovulation and 
prolong the estrous cycle. A year later, Prenant (69) expressed his 
opinion that the corpus luteum is a ductless gland which influences 
general metabolism and prevents ovulation from occuiTing during preg-
nancy and between periods of estrus. In 19001 the embryologist Gustav 
Born, as he lay near death, revealed to one of his former students, 
Ludwig Fraenkel, his belief that the corpus luteum is an organ of 
internal secretion which, in some way is involved in the preparation 
of the uterus for the implantation and protection of the embryo. After 
Born's death, it remained for Fraenkel to test this hypothesis. He 
found that removal of the corpora lutea from rabbits immediately after 
mating prevented the occurrence of implantation and placentation, and 
that removal before the twentieth d~ of pregnancy resulted in either 
absorption or abortion of the embryos (70). Loeb (71) further showed 
that removal of the corpora lutea in guinea pigs led to the appearance 
o£ the next estrus several days earlier than would ordinarily be ex-
pected. Later, he demonstrated that the growth of deciduomata produced 
by traumatization of the uterine endometrium of a pregnant animal was 
entirely dependent on the presence of corpora lutea (72). This was the 
first report suggesting that the corpus luteum might be involved in the 
promotion of the endometrial proliferati on necessary £or implantation. 
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Ancel and Bouin (73), extended this work and demonstrated that the 
elongation, secretion, dilation, and proliferation of the uterine 
glands during early pregnancy or pseudopregnancy in the rabbit could 
be prevented by removal of the corpora lutea. Corner (74) castrated 
female rabbits 14 to 18 hours after mating while the ova were at the 
two-celled stage, and on examinati on several days later found that 
progestational proliferation had not taken place and that the embryos 
had died in utero at the age of four days presumably because the uterus 
was not prepared to receive them. Thus, the inhibition of estrus, the 
promotion of progestational proliferation and implantation, and the 
maintenance of ~regnancy were fairly well established as functions of 
the corpus luteum. 
However, direct proofs were provided only when extracts of the 
corpora lutea were tested. In 1928, Hisaw (75), while studying luteal 
extracts which had the property of relaxing the public ligaments of 
the guinea pig, found that these extracts also were able to promote 
progestati onal proliferation. Weichert (76), using a similar extract, 
succeeded in sensitizing the uteri of castrated rats and guinea pigs 
for the production of deciduomata.. A year later, Corner and Allen, (77) 
and Allen and Comer (78) prepared alcoholic extracts of corpora lute a 
of sows which, when injected into castrated adult rabbits, produced 
progestational proliferation and When injected daily into rabbits cas-
trated 18 hours after fertile matings mai ntained pregnancy to term. 
Thus, the early findings o:f Fraenkel, Loeb, Ancel, Bouin, and Corner 
were confirmed by the classical methods o:f organ removal with replace-
ment therapy. Corner and Allen (77) named their extract "progestin". 
Later, when the exact chemical nature of the pure active substance be-
came known, Butenandt suggested that it be called "progesterone" and 
that the term progestin be reserved for crude luteal extracts (79). 
The elucidation of the physiology of progesterone: The effects of pro-
gesterone on the uterus: Progestational proliferation and implantation. 
The necessity of the luteal hormone for progestational proliferation 
and implantation was confirmed by Corner ( 80), Allen ( 81), and Pincus 
and Werthessen (82). Corner (80) reported that in the rabbit, 0.2 mg. 
of progesterone injected daily for five days could produce full proges-
tational proliferation. Pincus and Werthessen (82) showed that for 
successful implantation to take place in ovariectomized rabbits, 0.5 mg. 
of progesterone administered twice daily for the first 11 days of preg-
nancy was necessary. It may be concluded, therefore, that the proges-
terone requirement of the rabbit for the occurrence of implantation is 
over ten times that necessary to produce full progestational prolifera-
tion. 
D1Amour, et al (83) further investigated the possible beneficial 
effects of early progesterone treatment and claimed that daily doses of 
50 mg. given to intact pregnant rabbits during the first few days after 
copulation, favored the production of a higher than normal percentage of 
living embryos. On the other hand, other workers reported that early 
administration of progesterone produced adverse effects. They found in 
the rabbit that ova fertilized while active corpora lutea were present 
underwent delayed implantation and that daily injection of 0.1 to 0.2 
mg. of progesterone begun on the day after mating prevented implantation 
in some cases (84, 85, 86). A delay in implantation after the 
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administration of progesterone was also noted in mice ( 87). Cha.mbon 
(88) fo~d that in rats ovariectomized after mating and injected daily 
with 0.25 mg. of progesterone, fetal resorption occurred. The observed 
delays in implantation may have been due to the possibility that proges-
terone delays transport of the ovum through the Fallopian tubes (89). 
Since much of the early work on replacement therapy was done with 
relatively crude luteal extracts, it is not surprising that Hisaw and 
Leonard (90) and Hisaw, Greep, and Fevold (91) were able to show that 
if progesterone was given alone larger amounts were necessary to induce 
progestational proliferation than if the uterus was first sensitized by 
administration of another ovarian secretion; the follicular or estrogenic 
hormone. This was later confirmed by several other workers (81, 92, 93, 
94). Kehl and Chambon (95) also demonstrated that progesterone and es-
trogens interacted synergistically in the production of progestational 
proliferation, but Brouha (96) and Votquenne (97) found that, if the 
ratio of estrogen to progesterone exceeded 1 to 1000, there was a ten-
dency towards nullification of the effect of progesterone. 
Rowlands and McPhail (98) first observed that progestational proli-
feration could be induced in hypophysectomized, ovariectomized animals 
by injection of progesterone, and suggested that the action of proges-
terone on the uterus was probably direct. This view was later supported 
by McGinty, et a1 (99) who induced progestational proliferation by 
direct application of progesterone to the uterine endometrium. 
Formation of decidual tissues. Loeb's early demonstration of the ex-
perimental production of deciduomata.led to another line of research on 
the effects of progesterone on the uterus. Loeb (72) continued his work 
on the guinea pig and s·howed that corpus luteum removal prevented the 
decidual reaction, that the uterine sensitivity appeared at a definite 
time after ovulation, and that pregnancy prolonged the life of the deci-
duomata. Hannnond (100) confirmed these studies in the rabbit, and pro-
duced the reaction in pseudopregnant rabbits. Long and Evans (101) and 
Parkes (102) extended the studies to rats and mice, and found that the 
reaction could not be induced during a normal cycle, but only during 
pseudopregnancy and lactation when the corpora lutea were active. The 
antagonistic reaction between progesterone and estrogens was again 
suggested by Courrier and Kehl (103) who showed that in rats, deciduo-
mata could not be produced in one while placentae were present in the 
other presumably because of placental estrogen production. Selye, et 
al (104) presented supporting evidence by showing that the reaction 
occurred during the fourth to thirteenth days of lactation, but not 
during the first three cays. They suggested that failure during the 
first three days was becaus·e of the high titres of estrogen present at 
parturition. 
Motility. The fact that the rythmic contractions of the uterus vary in 
intensity durjng the various phases of the estrus cycle has long been 
known. Reynolds (105) reviewed the early work on this phenomenon and 
concluded that in spontaneously ovulating animals the major contractions 
occur during proestrus and estrus; during diestrus, pregnancy, and 
pseudopregnancy, they become much less pronounced. In animals like the 
cat and rabbit in which ovulation is induced by copulation, the uteri 
of non-pregnant animals are highly motile during the prolonged folli-
cular phase, but with development of corpora lute a during pregnancy or 
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pseudopregnancy the uterine myometrium is much less active. 
Knaus (106) studied the effect of progesterone on the uterus. He 
found that the induction of uterine contractions in the rabbit by the 
oxytocic principle of the posterior pituitary gland was inhibited 
during pregnancy and pseudopregnancy and that this lack of response was 
due to the presence of active corpora lutea. Makepeace, Corner and 
Allen (107) called this effect of progesterone "desensi tization11 and 
found that luteal extracts could produce it in rabbits, but only after 
pre-treatment with estrogens. Robson and his co-workers (108,109,110) 
demonstrated that the desensitization effect while present in rabbits, 
was not found in the cat, guinea pig, or mouse. Reynolds (111,112) also 
studied the effect of estrogens on uterine motility and found that, 
while estrogens enhanced it, progesterone could act as an antagonist. 
He showed that a normally stimulating dose of estrogen given in the 
luteal phase was completely neutralized by secretions of the young cor-
pora lutea. Robson (113) administered estrogens and progesterone in 
the ratio of 1 to 300 and found that the progesterone suppressed the 
effect of estrogens revealing its own dominance on the activity of the 
myometrium. 
Reports on the effects of progesterone on the muscular activity of 
the Fallopian tubes have been conflicting. Koh (114) did in vitro 
studies of tubal contractions in pigs, sheep and cows and found that 
the peristaltic contractions were minimal at a bout the time of ovulation 
indicating a possible inhibitory effect of estrogens. Seckinger (115) 
observed that the Fallopian tube of the pig underwent ten to fifteen 
contractions per minute at estrus, but only four to six per minute in 
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diestrus. 
Wislocki and Snyder (116) reported that the transport of ova 
through the Fallopian tubes could be hastened in rabbits if a new ovu-
lation or set of corpora lutea was induced during early pregnancy. On 
the other hand, Geist, ~ al (89) found that, after menopause in women, 
the Fallopian tubes lost their rhythmic contractility, but that this 
contractility could be restored by administration of estrogens. If 
progesterone was then administered, the tubal contractions elicited by 
the estrogen treatment were inhibited. Contrarily again, Burdick and 
Pincus (117) were able to prevent passage of ova through the tubes in 
rabbits by administration of small amounts of estrogens. 
Such conflicting results serve to emphasize the lack of definite 
kno-w·ledge about the hormonal control of tubal contractility and the role 
played by this phenomenon in the transport of the ovum. 
Menstruation. Although the occurrence menstruation is restricted to 
primates, it seems worthwhile to mention the role that progesterone 
plays in menstruation. 
Comer (118) and Corner and Allen (119) demonstrated that the ad-
ministration of progesterone to monkeys during normal menstrual cycles 
could delay the onset of the next menses, but that the menses would 
occur as soon as the treatment was stopped. Engle, Smith and Shelesnyak 
(120) further showed that the menstruation which invariably occurs follow-
ing withdrawal of a long estrogen treatment could be inhibited indefi-
nitely by progesterone administration. 
While the actions of progesterone and estrogens are apparently an-
tagonistic when given separately, when administered simultaneously, they 
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produce menses without withdrawal. Thus Zucker-man (121) and Corner (1~2) 
showed that if 1.0 mg. of progesterone was administered daily for ten 
days to castrated monkeys which had been receiving 100 to 125 I.U. of 
estrogen daily for a suitable period, menses occurred in four to five 
days after cessation of the progesterone treatment despite continued use 
of estrogens. Hisaw and Greep (123) studied the minimal dose of pro-
gesterone which would inhibit menses after a twenty day treatment with 
100 R.U. of estrogen daily. They were able to inhibit menses for 44 
days with 1.0 mg. daily, but when the daily dosage was reduced to o.5 mg. 
at the end of this period, menses occurred in four to seven days. These 
workers also found that there was a dose-response relationship between 
progesterone and its menstruation-inhibiting effect. Their results 
showed that 0.25 mg. daily delayed menses for six days; 0.5 mg. for eight 
to thirteen days; and o. 75 mg., for 15 to 25 days. 
Hisaw and Greep (123) also studied the interaction between proges-
terone and estrogens in the inhibition of menstruation, and showed that 
a dose of progesterone which ~ms non-inhibiting could act synergistically 
with estrogens if both were given simultaneously after estrogen treat-
ment. 
The effects of progesterone on the cervix and vagina. 
Very little work has been done on the effects of progesterone on the 
cervix. Allen (124) demonstrated in the monkey that just before ovu-
lation in the nor-mal cycle the cervical glands became elongated and 
coiled, and secreted mucus. He further shovred that this glandular de-
velopment could be stimulated by estrogen administration. Hisaw, Greep, 
and Fevold (91) reported that after castration the cervical glands and 
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epithelium became reduced in height and atrophic, but that either estro-
gen or progesterone treatment restored them to normal. 
Long and Evans (101) studied the cyclic . variations in the vaginal 
epithelium of the rat. They observed that vaginal smears taken during 
estrus contained only cornified cells. Towards the end of estrus, leuko-
cytes invaded the tissue, and subsequently a diestrous smear was obtained 
containing mainly leukocytes and cellular debris. Then towards proestrus, 
nucleated epithelial cells appeared which were again replaced at estrus 
with cornified cells. They also observed that in pregnancy the vaginal 
epithelium consisted of several layers of mucous cells. Allen (124) 
demonstrated that if castrated rats showing a smear similar to that of 
diestrus were injected with estrogen, cornificaticn occurred. Since 
this established that cornification was caused by the secretion of estro-
gen, it was assumed that the diestrous condition occurring in the luteal 
phase of the cycle and pregnancy must be controlled by progesterone. 
Indeed, this was proved to be true by several workers who showed in a 
variety of animals that administration of luteal extracts inhibited es-
trus and produced a diestrous condition (125,126,127 ,128,129). It was 
further shown by Robson (130) in the rat that the cornifying effects of 
0.2 u.g. of estrone were completely prevented by 750 u.g. of progesterone. 
Courrier and Cohen-Solal (131) showed that 8.0 mg. of progesterone in-
hibited the cornifying effects of 0.02 mg. of estradiol. Hisaw, Greep 
and Fevold (132) studied these antagonisms in monkeys which were cas-
trated and pre-treated with estrogens. They found that if progesterone 
was given, a thinning of the vaginal mucosa, an appearance of leuko-
cytes, and a decrease in mitotic activity occurred after 6 days. How-
ever, if estrogen was given after pre-treatment vdth progesterone, a 
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dose which would alone produce cornification had no effect. Robson (133) 
further demonstrated that progesterone also had a direct effect on the 
vagina, as ~ntravaginal application of progesterone was just as effec-
tive in inhibiting cornification as systemically administered proges-
terone. 
The previously mentioned investigators who found that corpus luteum 
extracts inhibited estrus also noted that they produced pronounced muci-
fication of the vagina. Because of this, many investigators first thought 
that the hormone of the corpus luteum, progesterone, was responsible. 
However, several workers later showed that progesterone alone was with-
out effect on the vagina, but that estrogen given in small amounts with 
progesterone could produce mucification (134,135,136,137,138). Although 
the ratios of estrogen to progesterone found necess~ to produce muci-
fication varied from about 500 to 1 to 1500 to 1 in the rat, Korenchevsky 
and Hall (138), Robson (130), Allen and Meyer (137), and Alloiteau (139) 
demonstrated that a balance of the two hormones was necessary. On the 
other hand Allen and Meyer (137), Meyer and .Ulen (140) and Selye, et al 
(136) were able to show that small amounts of oestrin, in the order of 
5.0 r.u. daily for 25 days in guinea pigs and .04 to .06 r.u. for eight 
days in the mouse produced vaginal mucification similar to that occurring 
in pregnancy. Thus, the mucification produced by corpus luteum extracts 
in early experiments was probably due to the presence of small amount of 
estrogen. 
Since certain workers have shown that if the ratio of progesterone 
to estrogen is lower than that necess~ to produce mucification, 
vaginal cornification takes place, current belief is that the effect of 
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progesterone on mucification is one involving the modification of 
estrogen action to sub-threshold effectiveness (130,134,139,141). 
Thus, mucification is considered to be attributable to levels of 
estrogen which are insufficient to produce cornifi cation (136,140, 
142). 
The effect of progesterone on ovulation and estrus. 
The early suggestion of Beard (68) that the corpus luteum might 
inhibit ovulation and prolong the estrous cycle led to a great deal 
of further study. Loeb (71) first showed that corpus luteum removal 
altered the estrous cycle in the guinea pig by shortening the inter-
vals between periods of estrus, and this was later confinned by other 
i'O rkers in the guinea pig, goat, and cow (143,144,145). 
However, the earliest attempts to inhibit ovulation by administra-
tion of luteal extracts failed probably because of the crudity of the 
early extraction techniques (146,147). The ovulati on inhibiting pro-
perties of progestin, oddly enough were first demonstrated in the hen. 
Pearl and Surface (148) were able to inhibit ovulation for up to three 
weeks. Other early workers noticed definite ovulation-inhibiting 
effects in rabbits, but. attributed this to possible contamination of 
their extracts with toxic substances (10,149,150). Haberlandt (10) 
noted three degrees of inhibition: complete inhibition of both 
ovulation and mating, inhibition of ovulation alone, and restoration 
of both ovulation and mating. Subsequent confirmations established 
that these findings were the results of actual physiological activi-
ties of progestin. 
Parkes and Bellerby (125) used an extract which, when i njected 
daily for ten days into rats, inhibited estrus for 20 to 25 days. 
Hisaw, Meyer and Weichert (126) inhibited estrus for six to twelve days 
by repeated injections of extracts equivalent to 5.0 mg. of tissue every 
four to five hours after a normal estrus in the rat. Haterius and 
Pfiffner (127), giving the equivalent of 5 to 10 mg. of luteal tissue 
per day, induced diestrous periods of from six to twelve days. In the 
mouse, Loewe and Lan ge (128) and Patel (151) found similar results. 
Macht, Stickel, and Seckinger (152) and Papanicolaou (129) were able to 
inhibit estrus in the guinea pig for as long as 70 days by injection of 
theequivalent of 5 mg. of luteal tissue daily. 
These early experiments merely established that extracts of the 
corpus luteum could in_llibit estrus. However, since the methods of 
extraction were very crude and variable, it is impossible to compare 
t hese results. Once progesterone was crystallized and the methods for 
its extraction standardized, studies of the inhibition of ovulation 
became more interpretable. 
Since the rat has an estrous cycle which is very easy to follow by 
studying vaginal smears, much of the early work was done with this 
animal. McKeown and Zuckerman (153) were able to induce a diestrous 
condition for as long as nine to eleven days by the daily injection of 
1.0 mg. of progesterone. Mazer an~ Israel (154) found 0.5 mg. daily to 
be completely ineff ective and 1~0 mg. daily partially effective, but 
4.0 mg. daily for 12 days completely suppressed estrus and corpus luteum 
formation. Astwood and Fevold (9) confirmed the eff ect of 4.0 mg. 
Phillips (155) showed that a minimum dose of 1.5 mg. daily was necessary 
to inhibit estrus indefinitely, but that after the last injection 
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regular cycles were resumed within three to five days. Everett (156) 
tested the effects of progesterone in rats wnich were in constant 
estrus and demonstrated that regular cycles could be restored by admi-
nistration of 0.25 to 1.0 mg. of progesterone daily, while a single 
injection of the same dose could induce periods of diestrus lasting 
for two to three days. He further found that the inhibition or delay 
of estrus in normal cyclic rats was more pronounced if the pro gesterone 
was given early rather than late in diestrus (157). Robson (158) 
working with the mouse, showed that the pro gesterone requirement to 
inhibit estrus indefinitely was siniilar to that of the rat. 
The classical work on the rabbit was done by Makepeace, Weinstein, 
and Friedman (8) who observed that as little as 1.0 mg. of progesterone 
daily prevented ovulation from occurring. They were also able to in-
hibit gonadotrophin-induced ovulation. Friedman (159) furthe r showed 
that progesterone could inhibit copper-induced ovulation. Dempsey (7) 
was able to inhibit ovulation by administration of as little as o.o5 
mg. of progesterone daily for 10 days. However, he also observed that 
within two to three days after the last injection, heat and ovulation 
occurred. Using higher doses of progesterone in single injections 
given at various times before mating, Pincus and Chang (67) found that 
with 10 mg. ovulation could be inhibited for as long as 11 days. With 
30 mg. ovulation was inhibited for at least 24 days. 
The inhibition of ovulation has also been studied in a variety of 
other animals. Marshall and Hammond (160) demonstrated that estrogen-
induced estrus in ferrets could be inhibited by progesterone. Dutt 
and Casida (12) reported that although 5 mg. was only partially e:f:fec-
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tive, 10 mg. of progesterone daily completely inhibited estrus and ovu-
lation in ewes. Ulberg, Grumm.er and Casida (lld showed that in gilts, 
25.0 mg. of progesterone daily inhibited heat and ovulation during the 
entire course of treatment. Animals receiving 50 mg. daily did not come 
into estrus until 7 to 26 days after the treatment ended. Ulberg, 
Christian, and Casida (13) found that in cows, 50 mg. daily suppressed 
heat and ovulation during treatment, and that post-treatment heat oc-
curred on the fifth day after t :00 last injection. Lower doses were not 
effective in every case, but when they were effective post-treatment 
heat occurred earlier than after higher doses. 
The above data suggests that although effective progesterone doses 
are not always directly related to body weight, within a species a dose-
response relationship exists. 
That luteal activity during pregnancy prevents ovulationfrom oc-
curring has long been assumed. However, Phillips (155) and Mazer and 
Israel (154) had the opinions that because doses of progesterone which 
were adequate to prevent ovulation ·in non-pregnant animals were much 
above physiologic levels, this theory did not hold. On the other hand, 
Robson (158) showed that in the pregnant mouse a concentration equal to 
that produced by the daily administration of 1.5 mg. of progesterone 
existed. Corner ( 80) and Neher and Zarrow (161) and other workers using 
other animals showed that blood progesterone concentrations in the 
blood during pregnancy were not out of proportion to doses of progesterone 
necessary to inhibit ovulation in non-pregnant animals. These results 
together with previously cited evidence from corpus luteum ablation and 
hormone replacement experiments completely refute the ideas of Phillips, 
Mazer and Israel. 
The mechanism through which progesterone inhibits ovulation is very 
likely one involving an inhibitory effect on LH release from the hypo-
physis. Direct and indirect evidences in favor of this theory have been 
reported by a great number of workers (7,8,14,162,163,164,165,166,167, 
and others). 
Although, under certain conditions progesterone administration may 
inhibit ovulation and estrus, under other conditions ovulation may be in-
duced or hastened. Rothchild and Fraps (168,169) and Fraps and Drury 
(169) reported that injection of as little as 0.5 to 1.0 mg. of proges-
terone into the hen caused ovulation to occur nine hours after tbe injec-
tion, but that this treatment was completely ineffective if the pitui-
tary v~s removed within two hours after the injection. If, however, pro-
gesterone was given sooner than 36 hours before ovulation was expected, 
ovulation was inhibited. Phillips (155) noted good inhibition in rats 
only if his injections of 1.5 mg. daily were started earlier than three 
days before the expected estrus. This was confirmed by Everett (157,164) 
who showed that 0.5 to 2.0 mg. of progesterone given to rats on the 
third day of diestrus accelerated ovulation by about 24 hours. However, 
if the same dose was given early in diestrus, ovulation was inhibited as 
long as the injections continued. He postulated that, during the times 
when the estrogen titre was high as near the tiiOO of proestrus and es-
trus, progesterone facilitates ovulation. Sawyer (170) showed that 2.0 
mg. of progesterone could facilitate ovulation in rabbits. Contrary to 
Everett's reports, he was not able to induce ovulation in estrous or 
estrogen-primed animals although a few estro gen-progesterone treated 
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animals ovulated spontaneously. He confirmed the inhibitory effect of 
progesterone, but postulated that preceding the inhibitory phase, pro-
gesterone was ovulation-inducing. Pfeiffer (171) also showed that pro-
gesterone stimulation of ovulation was possible in the monkey when 0.5 
mg. was given for three days beginning on the tenth to fourteenth d~ 
of the menstrual cycle. 
Several investigators have shown that in the rat, rabbit, cow, 
monkey and human, progesterone is secreted by the follicle just before 
ovulation (157,167,171,172,173,174,175). This evidence then suggests 
that a delicate progesterone-estrogen balance exists before ovulation, 
and that these hormones might act synergistically to stimulate ovulation. 
Pfeiffer (171) suggested that this synergistic action is upon the release 
of LH from the pituitary. It is probable, therefore, that the stimu-
lating and inhibiting effects on ovulation are dependent on precise 
timing and balances of titres of progesterone, estrogen, and luteini-
zing hormones. 
The effects of progesterone on fertilization and growtl1 of the ovum. 
There is a certain amount of evidence available supporting the view 
that progesterone can inhibit the fertilization of ova. Boyarsky, Bay-
lies, and Casida (11) reported that corpora lutea of pseudopregnancy or 
those formed after gonadotrophin-induced ovulation markedly suppressed 
ovulation in the rabbit. lr.hen 10 Rb.U. of progesterone was given daily 
for five days before mating, fertilization was not affected. However, 
when 20 Rb.U. was given for 10 dqys, only 5.2 percent fertilization oc-
curred. Boyarsky and his co-workers also noted that a few eggs were 
fertilized when estrogen was given three d~s before mating in the ten 
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day pseudopregnant rabbit, again shovdng an antagonistic interaction be-
tween estrogen and progesterone. These findings were confirmed by 
Murphree, ~ a1 (176). Moreover, these workers were able to show that 
while in pseudopregnant or pregnant rabbits artificial insemination into 
the vagina resulted in poor fertility, insemination into the uterus im-
proved the percentage of fertilization (177). They concluded that pro-
gesterone in some way interfered with the transport of spermatozoa. 
This view was supported by Austin (178) who further noted that the trans-
port of the fertilized ovum from the Fallopian tube to the uterus was in-
hibited in pseudopregnant rabbits. 
Pincus (92) reviewed work on the effect of progesterone on the fer-
tilized ovum and showed that progesterone stimulates ovum growth by 
making glutathione available for its metabolism. 
The effects of progesterone on the maintenance of pregnancy. 
Fraenkel's early work on rabbits showed that ablation of the corpora 
lutea before the tvrentieth day of pregnancy led to abortion or absorp-
tion of the embryos (73). He concluded that the corpora lutea were not 
only required for the preparation of the uterus for implantation, but 
also for the maintenance of gestation after implantation had occurred. 
Subsequently, many investigators concentrated on studying the possibility 
of the necessity of corpora lutea for the maintenance of gestation in 
various species. Pencharz and Long (179) and Parkes (180) demonstrated 
that in the rat and mouse the corpora lutea are necessary until they nor-
mally begin to regress at the seventeenth day of pregnancy. Herrick (181) 
and Snyder (182) reported that the corpora lutea are necessary only during 
the first trimester of pregnancy in the guinea pig. Hammond (183) and 
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Courrier (184) showed that in the rabbit corpora lutea are necessary 
throughout gestati.on. Snyder (182) stated that the corpora lutea are 
necessary until the forty-ninth day of the normally 64 day gestation 
period in the cat. Meites, et al (185) reported that the corpora 
lutea were necessary during the last trimester of pregnancy in goats. 
Uren and Raeside (186) found that they were necessary in the cow until 
at least the 200th day of gestation. Hartman (187), in his work on 
monkeys, showed that the corpora lutea were necessary dUring only the 
first 25 days of the 165 day pregnancy. Pratt (188) and Snyder (182) 
stated that the necessity of corpora lutea in humans was questionable, 
and that sufficient evidence was available to say that it was unneces-
sary beyond the first month of pregnancy. These findings tren point 
out that the requir ement of corpora lutea for the maintenance of preg-
nancy varies randomly among species. 
Evidence has also been presented that during a normal pregnancy 
there is an overabundance of luteal tissue. Corner (80) briefly re-
viewed the findings in the rabbit and concluded that only one of the 
several corpora lutea normally formed is necessary to mB:intain a 
normal number of embryos to term. More recently, Kelsey and Meyer 
(189) demonstrated that only two corpora lutea were necessary to 
maintain pregnancy in the rat. 
Allen and Corner (78) were the first to succeed in maintaining 
pregnancy to term in rabbits w.i. th luteal extract. They found that 0.5 
to 1.0 ml. daily of their crude extract was necessary. Later, Corner 
(80) showed that 0.5 to 1.0 mg. of progesterone gave the same result. 
Pincus and Werthessen (82) found that 0.5 mg. twice daily was necessary 
28 
for the first 11 days to insure implantation, but to maintain preg-
nancy 1.0 mg. twice daily was required. Courtier and Kehl (190) 
reported that 1.0 mg. daily was sufficient to replace the corpora lutea 
during the early stages of pregnancy, but that in later stages 5.0 mg. 
daily was necess~. Robson (130,191), using hypophysectomized rabbits 
with luteal atrophy, found that o. 75 mg. was required in early preg-
nancy, but that in later stages 2.0 mg. were required daily. Feyel-
Cabanes (192) confinned this, and found that 2.0 to 5.0 mg. daily was 
necessary, and that if less than o. 75 mg. was given none of the embryos 
survived. Zeiner (193) was able to maintain pregnancy in ovariectomized 
rats by injection of 2.0 mg. of progesterone at the time of castration 
followed by 10 r.u. daily of estrogen. Rothchild and :Meyer (194) and 
Peckham and Greene (195) reported that 2.0 mg. of progesterone daily 
maintained pregnancy in rats, and Robson (196) found the requiremant 
to be 1.0 mg. daily in mice. Meites et al (185) found that 10.0 mg. 
of progesterone daily was necessary to maintain pregnancy in goats after 
ablation of the corpora lutea in the last trimester. This evidence 
suggests that, although the progesterone requirement for the maintenance 
of pregnancy varies from species to species and is not related to the 
type of ovulation, length of pregnancy, number of embryos or body weight, 
more progesterone is required for the maintenance of pregnancy than to 
insure implantation. 
The antagonism of estrogens to progesterone was shown by Courrier 
and Jost (197) who found that the maintenance of pregnancy by progesterone 
in rabbits could be annulled by estrone when the proportion of estrone to 
progesterone was 1 to 325 by weight. Robson (196) showed that the mouse 
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was more sensitive to estradiol than the rabbit because in the former 
0.1 u.g. of estradiol or l/10,000 of the amount of progesterone neces-
sary to maintain pregnancy, interrupted gestation. The synergistic 
action of certain ratios of estrogen and progesterone was shown by 
Courrier and Jost (197). They found that, vmen the ratio of progest-
erone to estrogen was 7'50 to 1, pregnancy was m8.intained, and presented 
evidence that less progesterone was needed when given with estradiol 
than when given alone. 
Not only can progesterone replacement maintain pregnancy, but it 
m~ also prolong the gestation period beyond the normal limits. Nelson, 
~ !! (198), using an extract of sow's corpora lute a and beginning admi-
rd stration on the 16th to 18th day, were able to delay parturition in 
rats for five to s:Uc days. Portman (199) prolonged gestation in rabbits 
for two to three days by giving 2.0 to 3.0 Rb. u. of progesterone daily, 
and for as long as nine days by giving 4.0 Rb.u. daily at the end of 
pregnancy. Heckel and Allen (200) began injecting 1.'5 mg. of progesterone 
daily on the 20th to 28th day in rabbits, end this resulted in a delay 
of parturition for several days, but the embryos did not live beyond the 
35th day. Thus it has been shown by many investigators that if amounts 
of progesterone even less than those required for the maintenance of 
pregnancy in ovariectomized animals be given to intact animals towards 
the end of pregnancy and beyond, parturition will be dela,yed. Such 
treatment is equivalent to a prolongation of the life span of the corpar a 
lutea. Snyder (182) in a review of the factors involved in the duration 
of pregnancy su ggested that progesterone is involved in the prevent~on 
of uterine contractions and thus may inhibit parturition. 
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Chemistry and Metabolism of progesterone; Purification and synthesis. 
In 1929, just after the secretory activity of the corpus luteum had 
been established, several groups of workers undertook the problem of 
isolating the hormone from the ovary of the sow. This was accomplished 
almost simultaneously by several groups of· investigators in 1934, {201, 
202,203,204). It was found that -this hormone was a steroid similar in 
chemical structure -to the natural estrogens. The hormone of the corpus 
lutewn was subsequently named "progesterone" by Butenandt (202) -who 
suggested that the previously used term, 11progestin11 , be reserved for 
crude luteal extracts. 
The synthesis of progesterone was first accomplished by Butenandt 
(202) from stigmasterol, a sterol found in soy beans. More recent 
methods of synthesis from cholesterol, sapogenins, bile acids, and preg-
nanediol have been discussed in detail by Pearlman (221). 
Metabolism of progesterone. Several workers have demonstrated that 
administered progesterone is very rapidly metabolized (206,207,217,218). 
Zondek (207) reported that 48 hours after the subcutaneous administration 
of 2.5 mg. to the immature rat, less than 20.0 percent could be recover-
ed. Studies with radioprogesterone have revealed tha t in the rat and 
mouse most of the radioactivity, 88.0 percent and 51.5 percent respec-
tively, could be found in the feces, while 4. 7 percent and 26.0 percent 
respectively could be recovered from the expired carbon dioxide. High 
amounts of radioactivity were also recovered from the pituitary gland 
and the liver of both species. However, in mice a high concentration 
was also found in the adrenal gland where it is believed that certain 
adrenal steroids are formed from progesterone (206,208,209). 
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In 1937, Venning, Henry and Browne (210) first showed that the in-
jection of progesterone into women was followed by the urinary excre-
tion of pregnanediol, a compound first isolated from the urine of preg-
nant women by Marrian (211 ). Venning and her co-workers subsequently 
showed that urinary pregnanediol was a biologically inert metabolite 
of progesterone which combined with glucuronic acid and sodium and was 
excreted by the kidneys as sodium pregnanediol glucuronidate (212,213). 
Although other urinary metabolites of progesterone have been isolated, 
pregnanediol is the principle excretory product of rabbits and humans, 
but not of mice and rats (214). While it was shown that each molecule 
of pregnanediol in the urine represented one molecule of progesterone 
lea\dng the system, only about 9 to 16 percent of progesterone admini-
stered either orally or parenterally could be recovered as urinary preg-
nanediol. (215,216). 
Although it is not as yet certain, there is considerable evidence 
in favor of the theory that in the human and rabbit progesterone is 
converted to inert pregnanediol in the liver since injection of the 
hormone into the liver or into partially hepatectomized animals respec-
tively either decreases or enhances its progestational activity (217, 
218,219,220,221). On the other hand, there is also evidence available 
that the uterine endometrium may also be involved in the conversion 
(222,223,224). 
For a detailed surmnary of current chemical knowledge of pro-
gesterone metabolism, the recent publication of Dorfman and Ungar (214) 
is recommended. 
Assay of progesterone. Most of the methods of progesterone assay have 
utilized the reaction of the uterus to the subcutaneous administration 
of the hormone. Following the discovery of the hormone, Corner and 
Allen (77) devised a test in which 0.5 mg. of crystalline progest erone 
produced a minimal progestative proliferation of the endometrium, while 
1.0 mg. produced a maximum response. Clauberg (225) and McPhail (226) 
modified the test by first sensitizing the uterus to proges terone by 
administration of estrogens. Pincus and Werthessen (227) used rabbits 
ovariectomized 18 to 20 hours after mating and observed the effect of 
t he progesterone on endometrial proliferation and ovum growth. Astwood 
(228) developed a method based upon the degree of decidual response to 
traumatization produced after injection of progesterone into ovariecto-
mized, pseudopregnant rats. Other methods such as that of Knaus (106) 
which utilizes the fact that progesterone makes the uterine musculature 
r efractory to pituitrin and that of Duyvene (229) which depends on the 
effect Qf progesterone in lengthening the ovipositor in the female 
bitterling have also been used. However, none of these tests were either 
adequately sensitive or specific for progesterone. 
A fUrther modifi cation to increase its sensitivitywas therefore 
made, namely the direct injection of hormone into a segment of the uterus. 
Mussio-Fournier et al (230) observed a minimal response of the endome-
trium after injection of 0.1 mg. of progesterone, while McGinty ~ !! (99) 
reported that single in~ections of .ooo5 to .oo5 mg. injected i nto the 
uterus of .an estrogen-sensitized rabbit produced reactions within 72 hours 
that equalled those produced by o.5 mg. administered intramuscularly. 
Applications of .000125 to .00025 mg. produced a threshold reaction. 
Hooker and Forbes (231,232) developed a modified McGinty assay, but used 
changes in the endometrial stromal nuclei as an end point. They were able 
to detect as little as 0.3 u.g./ml. They later tested the specificity of 
the test using 24 steroids likely to be precursors, metabolites or con-
taminants of progesterone and found that progesterone alone gave a char-
acteristic response (232). 
A chemical approach to the analysis of progesterone was made by 
Haskins (233) who used a method based on the ultraviolet absorption of 
progesterone at 240 mu. However, in contradiction to Hooker and Forbes 
(231) he was unable to detect any progesterone in the blood he examined 
even though his method was sensitive to 0.1 u.g./ml. of plasma. Butt, 
Morris, Morris and Williams (234) developed a physico-chemical method for 
pregesterone determination based on extraction and final separation of the 
steroids by partition chromatography and subsequent polarographic estima-
tion. The sensitivity of this test was reported to be 0.1 u.g./ml. of 
plasma. These workers also found that in blood from IDegnant women there 
was less than 0.1 u.g./ml. agreeing with Haskins (233). These findings 
were contrary to those of Hooker and Forbes (231) and the authors suggest-
ed that the substance responsible for the high values reported by the 
latter was not progesterone or at least not progesterone alone. The 
development of physico-chemical means of progesterone determination may 
eventually eliminate the problems of sensitivity and specificity. 
Secretion of progesterone. Progesterone has been isolated from other 
glands as well as from the corpus luteum. In 1934, Adler, ~ ~ (235) 
found that distinct progestational proliferation resulted in the rabbit 
after administration of an extract of 600 gm. of fresh human placental 
tissue. Progesterone was detected in placental extracts by bioassay 
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methods as early as 1936, but isolation from placental tissue was not 
accomplished until 1952, and from placental blood in 1953 (236,237,238, 
239,240). Several workers have also shown by both direct and indirect 
methods that progesterone is present in the adrenal gland (260,261,262, 
263,264). Thus, the re are actually several sites of progest erone se-
cretion, but the major portion of this secretion is from the corpus 
luteum and the placenta. 
There is evidence that progesterone is secreted by the ovary before 
corpora lutea are formed. Many investigators have reported that imme-
diately after mating or just before ovulation in humans, monkeys, and 
rabbits progesterone was detectable in both the ovarian tissues and the 
blood (157,167,171,172,173,174,175). Although direct confirmation is 
needed, the re is evidence that progesterone is secreted by the mature 
follicle (246,247). 
Since it is only recently that accurate, sensitive, an d specific 
methods for progesterone deter.mination have been devised, many of the 
studies of progesterone s.ecretion levels during the estrous cycle and 
pregnancy which have been reported have been difficult to interpret. 
However, although many of the absolute values which have been reported 
are conflicti ng, certain trends of progesterone secretion have definite-
ly been established. 
Little work has been published on the progesterone content of corpora 
lute a during the estrous cycle. However, Kimura and Cornwell ( 248), using 
the Corner-illen assay, made a very careful study of this in the sow which 
has a 21 day estrous cycle. They found that, after ovulation, the total 
progesterone content of the corpora lutea rose f rom about 0.02 mg. to 0.15 
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mg. on the fifteenth day when the level began to drop sharply as the 
corpora lute a regressed. While the absolute values given are somewhat 
questionable, the rise and fall trend is obvious. However, this should 
not be considered as a direct indication of the rate of secretion as 
the histochemical studies of Dempsey and Bassett (246) suggest that 
while the most active secretion is taking place the corpora lutea 
actually contain the least hormone. Corner (80), using as a basis the 
fact that for progestational proliferation to take place in the rabbit 
0.2 mg. of progesterone is required daily for five days and that only 
one corpus luteum is necessary for this to take place, estimated the 
daily output of progesterone from all of the corpora lutea of one rabbit 
to be between 1.4 and 1.6 mg. Assuming luteal. tissue to be equally 
efficient volume for volume in other species, he estimated the daily 
output of the sow to be 32 mg. and that of the human to be 30 mg. These 
speculations, although interes ting, are based on the assumption that a 
unit weight or volume of luteal tissue, irrespective of species, produces 
a standard amount of progesterone, but the evidence available does not in 
any way support this assumption. 
More work has been done on the levels of circulating progesterone 
during the cycle. Forbes (249), working on humans, found that during 
the follicular phase of the cycle no progesterone was detectable. Pro-
gesterone first appeared either a day or two before or simultaneously 
with ovulation as determined by a body temperature curve. During the 
luteal phase, though his results varied from subject to subject, he found 
a general rise and fall with the maximum level of between 1.7 to 5.2 
u.g./ml. of plasma in mid-phase dropping to undetectable levels just at 
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the_ ~nd of menses. Forbes, Hooker and Pfeiffer (173) obtained similar 
results in the monkey except that the values observed, 2.8 to 7.0 u.g./ 
ml., were somewhat higher than in the human. While these absolute 
values must be considered with some reservation, a rise and fall of cir-
culatory progesterone between the time of ovulation and the end of the 
cycle apparently occurs. 
Estimations of the content of corpora lutea during pregnancy have 
been reported by Kimura and Cornwell (248 ). Their data showed that from 
about the fifteenth to the hundredth day of pregnancy, the total pro-
gesterone in the corpora lutea remained at a peak of about 0.25 mg. 
after which it dropped rapidly to undetectable levels at term on the 
12oth day. This work then showed that, contrary to the simple rise and 
fall of progesterone content in the cyclic oorpus luteum, in the corpus 
luteum of pr egnancy there was a rise to a peak which was maintained 
throughout the greater portion of the gestation period. 
Forbes (250) was the first to attempt to make systematic determi-
nations of circulating progesterone during pregnancy in women and 
monkeys. His determinations on humans resulted in such variable values 
that interpretation is difficult. However, there were indications that 
during the first 36 weeks, the blood progesterone remained at a level 
o:f about 1.0 u.g./ml. or less and that during the last six weeks, there 
was nearly a 100 percent rise with a drastic fall to undetectable levels 
just after term. This decline indicates that the secretion of the pla-
centa might well have been at least partially responsible for the sharp 
rise just before term. Forbes' work with the monkey did not parallel 
those with the human. Rather he found a gradual rise in the first 
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~_rimester to a peak of about 1.0 u.g./ml. of plasma which was maintained 
during the second trimester and followed by a gradual decline to un-
detectable levels after delive~. 
Neher and Zarrow (161), working on the ewe, found a pattern of pro-
gesterone secretion during pregnancy similar to that "Which Forbes found 
in the human, but the levels were about six times as high. In mice, 
Forbes (250) showed that the curve of secretory activity was biphasic 
reaching peaks of 7.0 to 9.0 u.g./ml. on days seven to nine and again on 
day fifteen diminishing thereafter until delivery. 
It has already bem mentioned that progesterone has been isolated 
from the placenta. However, no systematic investigations of the pro-
gesterone content throughout pregnancy have been published. 
It may be said, at this point, that analysis of corpora lutea, plasma, 
or placentae alone cannot give an accurate indication of the actual total 
secretion of progesterone. Rather, such estimates must be made simulta-
neously and the results combined with those obtained from all other pos-
sible sources such as the adrenal glan~ before adequate knowledge of 
secretion levels is obtained. 
Interaction of progesterone with other reproductive hormones; Interactions 
with hormones of the ovar¥• The antagonism of estrogens to progesterone 
was first noted in 1926 by Smith (251) who found that follicular fluid 
interrupted gestation in rats, and by Parkes and Bellerby (252) mo noted 
that the cornifying effect of follicular hormone on the vagina was mark-
edly decreased when active corpora were present. The possible synergistic 
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interactions of the two hormones was first noted by Hisaw, et al (91) 
who showed that more progesterone was necessary to produce proges-
tational proliferation in the castrated rabbit or monkey if given alone 
than if the uterus was first sensitized with estrogens. 
More recent investigations of these hormone relationships have shed 
some light on possible mechanisms involved. Byrnes and Meyer (253) 
demonstrated possible involvement of the pituitary. They showed that 
while low doses of estrogen inhibited FSH secretion, slightly higher 
doses enhanced LH production and estrogen secretion by the ovary. Still 
higher doses inhibit both LH and ovarian estrogen secretion. Further 
evidences for the involvement of the pit uitary in estrogen-progesterone 
interactions have also been reported (254,255,256,257,258). On the 
other hand, either parenteral or local administration of estrogens pro-
long luteal secretory activity in cyclic, pseudopregnant, and pregnant 
rats and rabbits (259,260,261,262). Thus, it appears that progesterone-
estrogen antagonism and synergism may ei t.her be mediated by direct in-
teraction or through the pituitary gland. Although the mechanisms are 
unknown, it is obvious that progesterone-estrogen interactions depend 
on delicate balances between estrogen, progesterone and pituitary hor-
mones. Pincus (92) gave a possible explanation of the importance of the 
estrogen-progesterone balance in certain known synergistic reactions. 
He stressed the possibility that both estrogen a nd progesterone may be 
destroyed by the same enzyme systems and that if a system should be 
saturated with, for example estrogen, progesterone would be destroyed 
more slowly and thus its action would be prolonged. This theory is 
substantiated by the reports of several workers that progesterone spares 
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the destruction of estrogens (275,276,277). 
The antagonistic and synergistic actions of progesterone end estro-
gen on the uterus, vagina, ovulation and pregnancy have already been 
discussed. Therefore, in order to avoid repetition here, the reader is 
referred to the section on the physiology of progesterone for additional 
information. The excellent review of Courrier (263) is also recommended 
as a reference. 
Progesterone, in certain instances,may also interact with another 
hormone of the ovary, relaxin. In 1926, Hisaw (264) discovered an 
ovarian principle which had the ability to relax the pelvic ligaments of 
the guinea pig. It was first thought that, since progesterone could also 
perform the same function, relaxation of the pubic ligaments occurred 
because of some interaction of progesterone with estrogen. Marden and 
Money (265) showed hovrever, that relaxin was a separate, non-steroidal 
hormone with no progestational properties. Although progesterone can, 
under certain conditions, relax the pubic ligaments, Marden and Money 
showed that it does so by eliciting relaxin secretion. 
Interactions wi. th hormones of the pituitary gland. Inhibitory and en-
hancing effects of progesterone on the release of gonadotrophin from 
the pituitary gland have already been discussed in the section on the 
physiology of progesterone. The inhibitory effect has been shown by 
both direct and indirect methods to be largely concerned with action 
antagonistic to the release of luteinizing hormone (7,8,14,162,163,164, 
165,166,167) and others). On the other hand, under certain circumstances 
progesterone may enhance LH secretion and induce ovulation to occur 
(157,164,168,170,171). This trophic influence on the pituitary is 
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believed to be because of synergistic action of progesterone with estro-
gen when the estrogen titre is high and the secretion of progesterone 
begins just before ovulation takes place (171). Recent irwest.igations 
have shown that in the rabbit, guinea pig, and rat, LH release is 
mediated by a neurohumoral rnachanism acting through the hypothalamus, 
(266,267,268,269,270). VIJhile there is evidence that estrogen and pro-
gesterone may act in part directly on the pituitary cells, it has been 
suggested that they may also exert their action on pituitary secretion 
by way of the centraL nervous system, (269). 
Early work showed that extracts from the pituitary gland containing 
prolactin, the lactogenic hormone, suppressed estrus in mice (18,19,270). 
'Astwood and his co-workers (9,271) later demonstrated that, while LH is 
responsible for the conversion of follicles to corpora lutea, a third 
trophic principle of the pituitary was involved in the maintenance of 
luteal function. He called this factor "luteotrophin." In 194l, Evans, 
et!! (272) showed that in the rat luteotrophin and lactogen were the 
same and that one of its activities was the maintenance of luteal secre-
tion. It has also been found that placental extracts contain luteo-
trophin (273,274). This information has prompted the suggestion by 
Astwood and Greep (273) that the corpora lutea of pregnancy might be 
maintained by luteotrophic secretions from the placenta. 
Other pharmacological actions of progesterone. 
Progesterone, although possessing definite and characteristic 
physiological properties, has also been shown to have physiological 
effects similar to those of other steroid hormones. The corticomimetic 
activity of progesterone was suggested as early as 1927 when Rogoff and 
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his co-workers discovered that if dogs were adrenalectomized during 
pregnancy or pseudopregnancy death did not occur until 47 to 58 days 
later than would be expected (278,279). It was later found by Gaunt, 
et al (280) and Green, ~!! (281) that daily administration of 1.0 to 
4.0 mg of progesterone to adrenalectomized rats resulted in survival for 
eleven to thirteen days instead of the expected three to seven days. 
This corticomimetic activity was confirmed by several other workers 
(282,283,284). Although several investigators have shown that admini-
stration of up to 4.0 mg. of progesterone daily to animals with i ntact 
adrenals has either no effect on adrenal weight or an atrophying effect 
involving the inhibition of adrenocorticotrophic hormone secretion, 
Kimelsdorf and Soderwall (285) noted an increase in adrenal weight with 
enlargement of the glomerulosa and reticularia zones (136,154,254,286, 
287,288). Although these reports are conflicting probably because of 
the varying doses of progesterone administered, much more work on 
adrenal-proges terone relationships is needed to resolve the problem. 
Androgenic properties of progesterone have also been described. 
Green, et al (289) and Kar (290) have shown that small doses of proges-
-- -
terone have a trophic effect on testicular development. Reciprocal 
effects of androgens and p~ogesterone have also been reported (153,291, 
292,293 ). 
Some of the more recent investigatibns of the properties of pro-
gesterone have been concerned with certain biochemical effects. That 
proges terone favors the deposition of energy-yielding glycogen in the 
endometrium has been established (123,294). During the periods of active 
luteal secretion, certain enzymes in the corpus luteum such as acid 
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phosphatase, succinic dehydrogenase, and adenosine triphosphatase have 
been shown to increase in concentration (295,296,297). On the other 
hand, progesterone administration has been demonstrated to reduce the 
concentration of b-glucuronidase in the vagina, liver, kidney and spleen 
while promoting an increase in esterase activity in the liver and spleen 
(298). Furthermore, prog~sterone may be involved in vitamin metabolism 
for Velardo and his co-workers demonstrated that aminopterin, an anti-
folic acid agent, prevented decidual development in intact, progesterone-
treated, and ovariectomized rats (299,300). Progesterone has also been 
shown to be concerned in the conservation of body water and certain 
electrolytes. Thorn, ~ ~ (301,302) reported that progesterone reduced 
water, sodium, and chloride excretion in adrenalectomized dogs, while 
it increased t:OO potassium output. Astwood (303) showed that the in-
crease in water content of the uterine endothelium after administration 
of estrogens was inhibited by progesterone. 
Up ·to the present time, reports on the biochemical effects of pro-
gesterone have been scant and very little of the work has been correlated. 
However, such an experimental approach promises eventually to reveal tl:B 
actual mechanisms of progesterone action. 
Other general physiological responses to progesterone administration 
have also been reported. That progesterone is thermogenic has been 
demonstrated by several workers who have noted a definite dose-response 
relationship which suggests the possibility that progesterone may be in-
volved in the body temperature changes often noted at the ~-me of ovu-
lation (304,305,306,307,308). Anaesthetic effects of progesterone have 
also been reported (309,310). 
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Certain toxic effects of progesterone administration have been 
noted on fetal and young · mice and rats. Symeonidis (311) and 
Karnofsky, ~ al (312), reported the induction of fetal death in mice 
and rats. Administration of progesterone to new-born mice had lethal 
action, but after two to three days a resistance developed so that by 
the seventh day the mice could tolerate 100 times more progesterone 
than on the first day. It was suggested that a mechanism for the 
detoxification of progesterone comes into play a few days after birth. 
Trentin (313) showed that, at a later stage, mice treated ~th proges-
terone had greater increases in body weight than did control animals. 
PRELIMINARY REMARKS 
In view of the problems of family plarming and population control 
alreaqy discussed in the introduction, an investigation of hormones as 
possible agents for the control of fertility seems both practical and 
desirable. Since progesterone naturally inhibits ovulation and plays 
a major role in controlling the sequence of events that occ~ in the 
reproductive process, it further seems desirable that this hormone 
should receive first consideration by the investigators of hormonal 
fertility control. 
Studies of the anti-fertility properties of progesterone and cer-
tain of its derivatives were recently initiated by Pincus and Chang (67) 
who used the rabbit as an experimental subject. They found that a 
single subcutaneous injection of 10.0 mg. of progesterone effectively 
inhibited ovulation for as long as eleven days, and that an injection 
of 30.0 mg. remained completely effective for at least 24 days. They 
also found that intravaginal deposition of as little as 1.0 mg. of pro-
gesterone prevented ovulation from occurring for from 5 to 24 hours. 
Using an oral progestin, ethinyl testosterone (anhydro-hydroxyproges-
terone or pregnenolone), they found 10.0 mg. to be over 87 percent 
effective, 5.0 mg. to be over 38 percent effective, and 2.0 mg. to be 
over 33 percent effective in inhibiting ovulation. They further found 
that 17-methyl progesterone, another derivative of progesterone, was 
effective for six days after a subcutaneous injection of 5.0 mg. and 
for at least 24 hours after intravaginal application of 5.0 mg. 
Since the results obtained in these experiments on the rabbit, an 
animal in which ovulation is normally induced only after copulation, 
varied according to dosages, routes of administration, and compounds 
used, a systematic investiga:tion of the effects of various methoos of 
administration of the same compounds in spontaneously ovulating animals 
with a different mechanism of ovulation was decided upon. Therefore, 
because of their easy availability, rats were chosen as subjects for the 
following experiments. 
The two progesterone derivatives, anhydro-hydroxyprogesterone, and 
17-methyl progesterone, were selected as other test compounds because 
of their known ovulation-inhibiting properties, and their different pro-
gestational effects. Since progesterone is kno-wn to be relatively in-
effective orally, anhydro-hydroxyprogesterone was chosen because of its 
oral effectiveness, because it has little progestational effect, and 
because it is non-toxic when given in large quantities (314,315,316). 
On the other hand, 17-methyl progesterone, · a recently synthesized de-
rivative of progesterone, was selected because of its kno-wn ovulation-
inhibiting ef fects and also because it has been shown to be twice as 
eff ective progestationally as progesterone (317,318,319). 
MATERIALS AND METHODS 
Selection and care of animals. Sexually mature, 'tlllbred albino rats of 
the Sprague-Dawley strain weighing between 150 and 250 grams were pur-
chased from the Charles River Co., Boston, Mass. Upon receipt of each 
shipment of females, the animals were carefully examined and those 
showing any evidence of abnormality, pregnancy, or disease were discarded. 
The screened females were then pooled in a large box and allowed to 
mingle for several minutes after which trey were randomly chosen, dis-
tributed six to a cage, and marked by ear p'llllcture. The size of the 
cages was approximately 12 X 12 X 20 inches. The male rats, selected 
from the laboratory breeding stock, were of proved fertility and were 
kept separate from the females in groups of four. All of the animals 
were fed corn and fox chow pellets ad libitum, and were housed in a 
well-ventilated, temperature-controlled animal room. 
Technique of vaginal smearing. Vaginal smears were iaken and recorded 
daily for three or more days prior to the beginning of an experimant in 
order that the animals might become accustomed to handling. This also 
served as an additional screening process since those animals which 
showed abnormal estrous cycles were eliminated from the experiment. 
The instrument used for taking smears was a pair of narrow forceps, the 
tips of which were tightly wrapped in cotton. The forceps were dipped 
in physiological saline, inserted one-half to three-quarters of an inch 
into the vagina, and turned completely arou,nd once. These precautions 
were taken l:oth to standardize the mathod of smearing and to minimize 
the possibility of any sexual stimulation. The swab of cotton was then 
rolled over the surface of a clean glass slide and the smear was 
immediately microscopically examined. The proportions of leukocytes, 
epithelial nucleated cells and cornified cells were roughly estimated 
and recorded. The smears were interpreted according to the classifi-
cation of Mandl (320). 
Preparation and administration of the test compounds. The test com-
pounds used in the experiments were crystalline suspensions of proges-
terone in physiologic saline supplied by the Syntex Co., Hatorey, Puerto 
Rico, and crystalline preparations of 17-methyl progesterone and anhydro-
hydroxy-progesterone supplied by Ciba Pharmaceutical Products, Inc., 
Summit, New Jersey. 
After the animals had become accustomed to handling, the test 
compounds were administered to the females by various methods. In no 
case did males receive any treatment. Crystalline progesterone was ad-
ministered as a 5o.o mg./ml. suspension in physiological sodium chloride. 
Due to the difficulty of preparing satisfactory suspensions of the 17-
methyl progesterone and anhydro-hydroxy-progesterone in saline, they 
were dissolved with gentle heating in propylene glycol at concentra-
tions of either 10.0 or 50.0 mg./ml. Control animals were either un-
treated or treated with propylene glycol. These substmces were ad-
ministered either orally with a two and one-half inch oral catheter 
attached to a syringe, subcutaneously by injection into the back of the 
neck, or intravaginally by means of a pipette. Treatments consisted of 
either single, once weekly, or twice weekly administrations and were 
given at random throughout the estrous cycle except in one series of 
experiments in which injections were timed according to the sequence of 
certain phases of the reproductive process. 
Procedure and timing of experiments. Approximately 24 hours after the 
first treatment, two males of proved fertility were introduced into each 
cage of six females. The daily taking of vaginal smears continued until 
the experiment was terminated. The males were changed weekly in order 
to avoid the consequences of possible variations in fertility. During 
the course of each experiment, the animals were periodically examined 
and those showing any signs of illness or abnormal behavior were elimi-
nated. An attempt was made to test each method of administration of each 
compound on at least two groups of six animals each. However, due to 
eliminations during the experiments, some groups consisted of only nine 
or ten animals. 
Criteria for mating, ovulation, pregnancy and age of embryos. The day 
during Which a smear containing spermatozoa was found was considered as 
the day of mating. About twelve to fifteen days after cohabitation was 
started and every two to three days thereafter, the females were palpated 
and when found to be pregnant were killed with ether. Mid-ventral laparo-
tomies were made and the numbers of corpora lutea in the ovaries and of 
normal and degenerated embryos were recorded. Crown-rump lengths of the 
nonnal embryos were recorded so that in cases where no mating record was 
available the ages of the embryos and the dates of mating could be es-
ti.mated by length comparisons with embryos of kno-wn age. 
P..istological examinaticns. In certain cases when animals failed to be-
come pregnant by the time an experiment was terminated, the ovaries and 
uteri were removed for microscopic examination. The tissues were fixed 
in Bouin's solution, dehydrated in alcohol, embedded in paraffin, and cut 
in sections of about six to seven micra in thiclmess. The slides were 
then stained in hematoxylin and eosin. 
RESULTS 
Control e eriments on untreated rats 
and rats treated w.i. th rop lene 
glycol: Mating and --~--~~~~~~~p~r~e~gna~~n~c~y~. In general, the results in the control 
experiments were similar in both untreated and treated 
animals shovr.Lng 
that the oral or subcutaneous administr t• f 
a ~on o propylene glycol had 
no effect on mating and pregnancy in rats (Table 1). Administration of 
propylene glycol was in every case started 24 hours before the males 
were placed in the cages w:i. th the females. Table 1 shows that although 
a few of the animals failed to mate as early as would be expected, the 
average number of days between the times cohabitation was begun and 
successful mating ~curred was much the same in every group. Since the 
occurrence of successful mating was not del~ed beyond the four to five 
days normally expected in untreated animals, estrus was not inhibited. 
The numbers of corpora lutea found in post mortem examination after 
pregnancy was established varied very little between groups. Thus, 
ovulation was apparently not Affected by the control treatments. The 
percentages of ova ovulated (estimated from the numbers of corpora lutea 
found) which failed to become implanted and were, t herefore, either not 
fertilized or became degenerated before implantation also varied little 
among all but one of the groups. The animals receiving single oral 
doses of 1.0 ml. of propylene glycol had a high percentage of ova (42.7) 
which were unaccounted for. It is very difficult to explain this, but 
as the investigation progressed it was realized that this result was ·an 
extremely rare occurrence. Again, the percentages of embryos which 
degenerated after they became implanted varied little. However, in the 
same group just mentioned, the percentage was muCh higher (15.1) than 
in the other groups. This result is also difficult to explain and was 
found to be a rare occurrence. 
Table 2 presents averages for all the control groups combined. 
While the range and average of the number of d~s between cohabitation 
and successful mating were 3.5 to 8. 7 and 5.4 respectively, the records 
of vaginal smears show that 65.0 percent of the matings took place during 
the first five days and 77.0 percent durin g the first eight days, while 
a few mated as late as the thirteenth to 28th days after the males were 
introduced. Although the average numbers of corpora lutea varied very 
little (112. to 13.6), the ,average numbers of normal embryos (6.6 to 
11.3) varied consider~bly and were in every case less (av. 80.0 percent) 
than the number of ova ovulated as estimated from the number of corpora 
l utea found. Therefore, t hese control experiments showed that approxi-
mately 20.0 percent of the ova were either not fertilized or became de-
generated before or after implantation. The table furtre r shows that 
actually 14.0 percent of the ova were eitrer unfertilized or became de-
generated before implantation and that 6.0 percent of t be embryos t hat 
became i.'D.planted failed to develop into normal embryos. 
Table 3 presents the data obtained from measuring the crown-rump 
lengths of the normal embryos. When a pregnant animai was killed, the 
embryonic membranes were removed and the embryos were measured. An 
average figure was. taken for the lengths of tlE embryos from each animal 
and this figure was recorded together with the age of the embryos as de-
termined from the dates of mating and killing. The table gives average 
figures for embryos of the same age from different animals. 
Mating and estrus. Table 4 gives further information about mating and 
estrus gained from taking vaginal smears. Th 
e data were taken only from 
records of vaginal smears that were complete and,therefore, the numbers 
of animals do not necessarily corTespond with those listed for the various 
control groups in Table 1. In a few cases mating occurred twice w:i.. th 
the first attempt unsuccessful. A mating was considered to have occurred 
if spermatozoa were found in a smear. A total of about 5.0 percent of 
the control animals mated twice. It would ordinarily be expected that 
the first mating should take place during the first estrous period oc-
curring after the males were introduced into the cages. However, Table 
4 shows that this was not true in all cases. Several animals (18. 7 per-
cent) did not mate unti~ the second and in one case not until the third 
estrus as determined by vaginal smears. In all cases the estrous periods 
were clearly indicated by the smears, the great majori4f of the cells 
being of the cornified type. 
The average length of the estrous cycle in rats is four to five 
days with full estrus occurring at about the same intervals (105,350). 
However, in some animals estrus does not occur at perfectly regular in-
tervals. In some cases a period of estrus is even skipped. The third 
column in Table 4 shows that after the males were introduced in 18.7 
percent of the females the next estrus period did not occur until some 
days after it was expected. In these animals the delay of estrus was 
from three to eighteen days beyond the time it was expected after the 
males were introduced. The gverage delay of full estrus was 7.4 days 
for the combined control groups. 
Relation between the time of administration and the occurrence of mating. 
Since propylene glycol was administered to trn animals at random during 
the estrous cycle, data from the records of vaginal smears taken at the 
times of administration were compiled to show if administration during 
any particular time in the cycle had a specific effect on mating or 
estrus. These data are shown in Table 5. For convenience, the cycle is 
divided into three phases, early estrus, es:trus, and diestrus. In all 
cases the males were introduced into the cages 24 hours after admini-
strations were begun. It can be seen that administration of propylene 
glycol during early estrus resulted in the occurrence of mating on the 
average of 6. 2 days after the males were introduced. Administration 
during estrus resulted in the occurrence of mating after 6.1 days, while 
administration during diestrus resulted in mating 2. 7 days after the 
introduction of the males. The sequence of phases of the estrous cycle 
consists of approximately two deys of diestrus followed by one day of 
early estrus and then one day of estrus. Thus, animals given propylene 
glycol while in early estrus came into full estrus on t:te next day when 
the males were introduced. Untreated animals which were in estrus when 
the males were introduced mated on the aver age of five days later indi-
cating that mating usually occurred during the next estrus. The delay 
of 6.2 days noted in the treated animals was somewhat higher but this 
was probably because the number of animals was larger and because in 
several animals estrus periods did not occur regularly (see Table 4), 
Animals given propylene glycol while in estrus were actually in the 
first day of diestrus when the males were introduced, while untreated 
animals to which males were introduced at the same time mated in an 
average of 3.5 days. Treated animals mated on t he average of 6.1 days 
later. Again this figure is higher, but probably because of the same 
reasons stated above. Rats given propylene glycol while in diestrus 
could either have been in the second day of diestrus or in early estrus 
when the males were introduced. While untreated animals mated on the 
average of four days later , the treated animals mated i n 2.7 d~s. 
Again these figures cannot be considered to be contradictory consider-
ing the irregularity of cycles and the numbers of animals in each group. 
In general, it is indicated that propylene glycol did not have 
differential effects on mating "When administered duriilg the various 
phases of the estrous cycle. 
Microscopic examinations of ovaries and uteri from untreated rats. 
For purposes of eventual comparison with tissues from experimentally 
treated animals, ovaries and uteri were taken from untreated rats in 
early estrus, estrus and diestrus and prepared for microscopic 
examination. 
Figure 1 shows a section taken from a rat in diestrus. Corpora 
lutea of different sizes formed after ovulation in previous cycles are 
present. Large numbers of immature follicles can be seen rear the 
central portion of the ovary while towards the periphery many growing 
follicles in various stages can be seen. Most notable is the absence 
of mature or Graafian follicles. Figure 2 shows a cross section of 
the uterus from the same animal. One can see that the uterus is not 
distended, the lumen being small and rather flattened. The endome-
trial surface is arranged in broad, rather flattened irregular folds. 
Glands in the endometrium show a minimum of coiling. The majority are 
round to oval in shape and appear quiescent. The endometrium, however, 
is rather thick, about two and one-half times as thick as the myometrial 
layer. 
Figure 3 shows a section of ovary taken from a rat in early estrus. 
If this is compared with the diestrous ovary it can be seen that although 
the numbers of immature follicles seem to be about the same, growing 
follicles are less· numerous. This is very likely true because, although 
none were found in the diestrous ovary, in this ovary several mature 
Graafian follicles are present. Figure 4 shows a section of uterus from 
the same animal. Here it can be seen tm t the uterus is distended, tl'E 
lumen being quite large. The endometrial glands are more of the elongated 
and coiled types showing increased activity. The endometrial thickness 
is somewhat reduced, the proportion of endometrial to myometrial thick-
ness being about 2 to 1. 
Figure 5 shows a section of ovary from an animal in es t rus. The types 
and numbers of follicles are approximately the same as in the ovary in 
Figure 3. Figure 6 shows a section of the uterus from the same animal. 
Again, the uterus is distended, the lumen being very large. The endo-
metrial surface consists of fingerlike projections. The glands are 
elongated and coiled appearing to have about the same activity as those 
in Figure 4. However, the endometrium has become reduced in tllickness, 
the proportion to the muscle layer being about 1.5 to 1. 
In general, changes in the ovary as an animal passes from diestrus 
to es t rus consist mainly of rapid maturation of the follicles. The 
changes in the uterus are characterized by increased glandular develop-
ment, reduction in endometrial thickness with proliferation into finger-
like projecti ons, and progressive distention of the lumen with fluid. 
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TABLE 1 
Control experiments on pregnancy in untreated rats and rats treated with various 
dosages and methods of administration of propylene glycol. 
Treatment 
Dosage 
Method (ml.) 
Days between co-
habitation and 
successful 
mating 
Mean Range 
Average 
no. of 
corpora 
lute a 
Average 
no. of 
normal 
embryos 
Ova unfertilized 
or degenerated 
before 
implantation 
(%of C.L.) 
Degener-
ation • 
(% total ~ 
embryos) ! 
None - ! 4.4 _:~ 11.2 _.2:l._.+----:2:5 H l , __ 4.1 ---t 
Or~y I ! ! . ~ s~;i• 1.0 1--3.5 ~ -.. -· -~~7-~·- ~-t·. ~-~~-~5·:_.~ 
twice 0.5 l 4. 7 0-13 12.2 11.3 1 5.5 1.4 1 
~-----+--'--'" '"~~~~-~-~~=----~+ ·-~- ... ~~----Lg-- -~~---~---~ -· 
Single j I ~ I 
injection 1.0 I 8. 7 2-27 j 11.8 10.1 J 7.6 I 7. 7 _ 
Injection l ·~-r--~~~r--~-~T - - . 1= ~ ~ - . I 12 
6 once ' 0.2 l 5.0 1-14 I' 12.7 11.2 I 8.0 l 4.3 I 
weekly l I ~ J--+--~-......_;--,"'-+·~--,. r-~---,--t-~"""-~--~- ·-. --:--<~~-=--~-----i~~~-~.,.,.-~~=-""-=~=-~~--- _., ___ _ 
Injection . I I i ~ ~ 
5 
6 
twice I 0.5 lj 3.2 1-8 I 11.2 10.6 ~ 5.4 l o.o 
weekly I 0.2 8.0 1-28 12.7 l 9. 2 ~ 20.0 I 9.8 
J I I 
~I 
TABLE 2 
Contr ol experiments . Data on pr egnancy and mat ing for all groups combined • 
. 
! l l 1 l . ~ Av. no. days ' l Av. no. ova ~ between co-
' 
i unfert. or ~ habitation % of mat- Av. no. l Av. no. of nor- I degen. before I Degeneration 1 No. ! and success- f ings occur- of c.L. mal embryos implantat ion (% of total J rats ~ ful mating. I ring in: (ova) (% of C.L.) , embryos) . ~ . I 
i f l I I f I a I Fi rst First I I 'Range I Av. i 5 8 Range Av. Range Av. %c.J .... Range Av. Range Av. ~ %C.L. 
I I days days I I I l 
' 
i I ' ! 61 3.5 5.4 I 65.0 77.0 11.2 12.2 6.6 9.8 8o.o 5.5 14.0 o.o 6.0 6.0 
I to to to ]_ 4t 7- to 8.7 13.7 11.3 ~J - 15.1 
-- -- - -- - -- - - --
-- - ----
- ·-- -
-
~ 
I 
I 
l 
1 
j 
I 
TABLE 3 
Average crown-rump lengths of em-
bryos of various ages. Control 
groups combined. 
No. 
~ge f I 
Crown-rump ~n ~ rats days length in mm. 
I 
Range Av. 
-
5 
I 
- -
6 
- - -
7 -
- -I I - 8 - -
- 9 - -
-
10 
-
... 
4 11 8.0-10.0 8.8 
~ 
2 12 I 10.0 10.0 
3 13 10.0-11.0 10.7 
5 14 9.0-12.0 11.0 
7 15 12.0-15.0 13.5 
5 16 15.0-16.0 15.2 
4 17 16.0-20.0 18.5 
-
18 
- -
5 19 25.0-41.0 31.8 
-
20 
- -I 
2 21 41.0-43.0 42.0 
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TABLE 4 
Control experiments. Effects of propylene glycol 
on mating and estrus in rats. 
Failed to 
Mated twice: mate at first 
second sue- signs of 
cessful. estrus.l 
No. of days first full 
estrus delayed beyond 
time expected after 
cohabitation. 
! No. % No. % No. (Delay) % 
3/60 5.0 11/60 18.7 11/60 (3-18 days) 18.7 
(av. 7.4) 
1. All but one mated at second signs of estrus. 
2. 1/6 (16. 7% mated once, but failed to become pregnant. 
3. Did not IIlate until third estrus. 
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TABIE 5 
Control experiments. Effect of administration 
of propylene glycol during various phases of 
the estrous cycle on the occurrence of mating 
in rats. 
Time of 
Admini- No. No. of days mating delayed 
stration rats after cohabitation 
Range Av. 
Early 11 1-16 1 6.2 
estrus ---·---~--- .. ...- · ----·-·----~---~- · 
Estrus 16 0-21 . 6.1 
-
-- -- -·--- -·------~-·--· !-----·~--.-.. -··· ·~·--
Diestrus 20 0-10 2.7 
60 
~ 
I 
~ 
Experiments on the administration of progesterone: Mating and . 
pregnancy. Table 6 presents the data obtained from experiments in 
which the female rats were treated with oral and subcutaneous admin-
istrations of progesterone. The results reveal that the treatments 
with progesterone had no adverse effects on fertilization, implant-
ation or normal development when compared with controls. This is more 
clearly shown in Table 7 in which average values obtainedfrom the groups 
receiving various types of administration of progesterone are compared 
with corresponding control values from Table 2. Table 7 shows that once 
mating and ovulation occurred, treatment had no consistent effect on the 
number of ova produced, the percentage of ova unfertilized or degenerated 
before implantation, or the development of embryos once the ova became 
implanted. 
Although none of the treatments had any effect on the reproductive 
events following successful mating, Table 6 shows that there were defi-
nite effects on the occurrence of ma tj.ng. The results show that sub-
cutaneous injection of progesterone was more effective than oral admi-
nistration in prolonging the intervals between the beginning of cohabi-
tation and successful matin~. The effectiveness of oral administration, 
however, was not related to the dosage. In groups receiving 25, 10, and 
5 mg. of progesterone orally, the mean intervals between cohabitation 
and mating ranged from 10.9 to 13.0 days, two to four days longer than 
the longest mean interval in the control groups. The m3an interval for 
these three doses in 11.3!'1.55 which is significantly different from 
the mean of all control animals, 5.5±0.760. However, there is no sig-
nificant difference between the groups receiving 50 mg. and the control 
.-animals. The effect of oral administration in delaying the occu.n-ence 
of mating must be of short duration because the data presented in Table 
7 show that 56.0 percent of the matings in the combined groups took 
place in the first eight days as compared with 77. 0 percent in the con-
trol animals. Even feeding 5 mg. of progesterone twice weekly did not 
prolong the effect. Table 6, however, shows indications that the oral 
administration of 5 mg. of progesterone twice weekly may have some 
adverse effects on fertilization, implantation, and normal development 
because only 53.0 percent normal developement resulted as compared with 
an average of 80.0 percent in the control mimals. This difference, 
however, is not statistically significant. 
While the effects of oral administration on the delay of mating 
were somewhat inconsistent, those of injection were very decided. 
Single injections of 2 to 50 mg. of progesterone prolonged the average 
interval between cohabitation m d mating from two to nineteen days 
beyond the longest average in·terval in the control groups . Moreover, 
the effectiveness of injected progesterone was very closely related to 
the dosage. This is clearly shown 1:rf the occurrence of the first 
matings four, three, si.x, twelve, and eighteen days after cohabitation 
began in the groups injected with 2, 5, 10, 25, and 50 mg. respectively. 
Graph 1 presents the dose-response relationships of oral as compared 
with subcutaneous administration of progesterone. A clear dose-response 
relationship can be seen with injection 'While no such relationship eXists 
in oral administration. The effectiveness of injected progesterone is 
also of long duration because 90.0 percent of the matings in the groups 
receiving 25 and 50 mg. and 60.0 percent in those receiving 5 and 10 mg. 
took place after 20 days of cohabitation as compared with 77.0 percent 
in the first 8 days in the control animals (Table 7). Table 7 further 
shows that once successful mating had occurred there was no effect on 
subsequent phases of the reproductive process. Since many of the animals 
treated with progesterone were allowed to deliver before embryo measure-
menta were taken, t he data in Table 8 .are scanty. However, it is indi-
cated that progesterone had no effect on the growth of normal embryo 
' 
as the values were similar to those of controls. 
Injection of 2 or 5 mg. of progesterone twice weekly was most 
effective and with this type of administration the possibility of in-
hibiting mating indefinitely was indicated. This was true of the group 
receiving 5 mg. The first group received 5 mg. of progesterone twice 
weekly for nine weeks after which for personal reasons of the investi-
gator it was necessary to stop the experiments. All 10 of the animals 
were killed at this time and only three were found to be pregnant. 
Some time later the experiment was repeated on eight animals. Treat-
ment was given for eight weeks and then the animals were allowed to 
remain alive until they became pregnant. Three of the eight animals 
actually had become pregnant before the treatment was stopped. They 
had mated successfully on the fifth, fourteenth, and forty-third days 
after introduction of the males. The remaining five animal.s mated 
successfully 6, 12, 35, 31, and 58 days after the injections were stopped. 
The results obtained from the animals which received repeated injec-
tiona of 2 mg. of progesterone were somewhat different. The inhibition 
of mating in these animals did not persist indefinitely. The rats were 
treated with progesterone for two months and after that time, when 
pregnancy was indicated, they were ldlled. It was found in all nine 
animals that mating had definitely been inhibited for 13 to 55 days, 
but that all had successfully mated before the treatment was stopped. 
It is indicated, therefore, that after a certain period there is an 
adaptation of the ovulatory mechanism to this inhibitory dosage thus 
permitting ovulation to occur in spite of the continuing administration. 
Mating and estrus. Table 9 presents more data on mating and estrus in 
the animals treated with progesterone. It can be seen by comparison 
with Table 4 that the occurrence of unsuccessful matings was no more 
f-requent than in control animals. However, the occurrence of partial 
estrous periods in which the female would not accept the male did occur 
in a higher percentage • . In control animals about 18.7 percent did not 
mate until the second or third estrus period. However, all of the estrous 
periods were full as indicated by vaginal smears. In animals treated 
orally with progesterone, these percentages were higher than in controls 
indicating that this type of administration of progesterone resulted in 
the occurrence of estrus periods in which mating did not occur. The 
records of vaginal smears show that not only were these periods of estrus 
irregular in occurrence, but that they were futhermore only partial, since 
full cornification did not occur. 
The injected groups showed an even greater response to progesterone. 
In these animals the majority had either very few or no estrous periods 
even of the partial type. Rather, no detectab1e evidences of estrous periods 
was noted until finally a full estrous period occurred and successful 
mating took place. Table 9 also shows the percentages of animals in which 
:full estrus, which is indicated by acceptance of t he male, was delayed 
beyond the time it was expected after cohabitation was started. In the 
orally treated groups 50.0 to 78.0 percent of the animals had delayed 
full estrus while in the injected group the percentages were 81.0 to 
100.0. Also the average delay was considerably longer in the injected 
groups again indicating the relative effectiveness of each type of admi-
nistration. In all cases of animals treated w.i.. th progesterone, the 
numbers of animals 'With delayed full estrus was higher than the average 
for the control groups. 
Relation between the time of administration and the occurrence of mattng. 
Table 10 presents data on the effect on mating produced by the admini-
stration of progesterone during various phases of the estrous cycle. 
Dat a are taken only from those groups from which accurate records of 
vaginal smears had been taken. When compared with control animals 
(Table 5) it can be seen that mating in animals receiving 50 mg. of' 
progesterone orally was not affected by the time during the cycle at 
which treatm.en t was given. Mating was delayed three to five days beyond 
that occurring in control animals when progesterone was given in either 
early estrus, estrus or diestrus. In the rest of the orally treated 
animals, the delay occurring after treatment at estrus was shorter than 
when it was given at other phases of' the cycle. Adninistration during 
early estrus or diestrus made no difference in the time of mating. Al-
though the data are not consistent in all cases and should be supple-
mented to give more marked results, the shorter delay in mating after 
administration in es t rus might have occurred because of the possibility 
that, since it is of short duration, the effect of progesterone is sub-
threshold by the time the next estrus occurs four to f'ive days later. 
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In animals receiving progesterone during early estrus or diestrus, the 
inhibition by progesterone might still be in effect by the time the next 
estrus occurs in one to three days. 
In animals given progesterone by injection in either estrus or diestrus 
there appeared to be no distinct differences in times of mating. This is 
possibly because injected progesterone produces an effect of much longer 
duration than that of orally administered progesterone. 
Effects of administration of progesterone at various times during pregnancy. 
Since the injection of progesterone produced a marked effect on mating and 
estrus, experiments were performed with small groups of animals to see if 
low doses given at various times after normal mating would have any effect 
on subsequent developmental processes. Table 11 presents the data from 
these experiments. 
In the first group, 5 mg. of progesterone was injected subcutaneously 
into the females immediately after a vaginal smear was found containing 
spermatozoa. This was done in order to test whether the progesterone 
might inhibit the transport of spermatozoa, and· thus prevent fertilization 
or cause degeneration of the fertilized ova in the Fallopian tubes. Values 
from Table 2 as well as those from the other experiments in this group were 
used as control data. It appears that in this experiment all of the data 
are within control limits except the percentage of ova unfertilized or 
degenerated before implantation which is about twice as high as that ob-
served in control animals. This is an indication that progesterone pos-
sibly does affect fertilization or ovum transport through the reproductive 
tract. 
Another experiment was performed in which progesterone was injected 
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two days after mating. Since it is at about this time that the ovum 
normally approaches the uterus, the experiment was designed to test the 
effect of progesterone on implantation. Again all values obtained were 
comparable to those of control animals except the percentage of degene-
rated ova. Thus, it is indicated that the injection of progesterone 
either caused the degeneration of the ova per ~ or somehow prevented 
implantation from occurring. 
The third experiment in this group was designed to test the effect 
of progesterone on the development of embryos after implantation. There-
fore, 5 mg. of progesterone was injected into animals which had been 
pregnant for 13 to 18 days. The results show that no other phase of tl:B 
reproductive process was affected other than the degeneration of embryos 
after implantation. This percentage was three to four times as high as 
in control animals from the other two experiements in the series and 
six to seven times as high as in control animals in Table 2. The indi-
cation then is that small doses of progesterone have adverse effects on 
embryonic development, after implantation. 
Microscopic examination of ovaries and uteri from animals treated with 
progesterone. Figure 7 shows a section of ovary taken from an animal 
35 days after a single injection of 50 mg. of progesterone. Although 
males were in the cages all this time, the animal was not pregnant when 
ld.lled. The ovary has a rather normal appearance similar to those from 
animals in early or full estrus (Figures 3 and 5). Some mature follicles 
are present. Since the animal had not mated for 35 days, it is somewhat 
surprising that ovulati on was about to occur at the time it was ld.lled. 
However, other animals treated in the same manner mated only after 18 to 
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40 days. Thus, it is very possible that at the time the animal was 
killed the effect of the progesterone was wearing off and that the 
animal might well have come into estrus, mated, and ovulated within a 
short time. Figure 8 shows a section of uterus from the same animal. 
Although the lumen is not distended, the endometrial surface consists 
of finger-like folds similar to those seen in animals in estrus. The 
endometrium, however, is thicker, the proportion to the muscle layer 
being about 4 to 1. 
Figure 9 shows a section of ovary from an animal 35 days after a 
single injection of 25 mg. of progesterone. The ovary is essentially 
similar to that of an animal in diestrus (Figure 1). No Graafian 
follicles are present. Figure 10 shows the uterus from the same animal. 
In general, it is very similar to the uterus shown in Figure 8 except 
that the endometrial thickness is greater in proportion to that of the 
muscle layer (about 5 to 1) and its surface is not quite as folded. 
In general, it might be said that the injection of progesterone 
causes an animal to remain in a reproductive state similar to that of 
diestrus for periods up to 35 or more days. Additional evidence in 
favor of this is that vaginal smears taken from non-pregnant animals 
injected with progesterone were similar to those of untreated animals 
in diestrus. Another marked effect of the progesterone was on the 
thickness of the endometrium which was about twice that of any of the 
control animals. 
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Treatment i 
l I No. 
TABLE 6 
Effects of various dosages and methods of administration 
of progester one on pregnancy in the r at . 
Days between co- Ova unfertilized 
habitation and Average Average or degenerated 
successful no. of no. of before 
Dosage mating corpora normal implantation 
J 
Degener-
at ion 
(% total '' I rats Method l_m_g.J~ _) !ean Range lutea embryos (% of_~Q_._L_!_L ____ emb~s) 
I I . f 17 I 20 16 
9 
Single 
oral 
! I 50.0 I 8.8 1-28 13.0 10.3 
.,I 25.0 ! 10.9 1-37 11.8 10.1 
J 1o.o 1 1o.9 1-29 11.3 10.3 
5.0 13.0 4-42 9.4 8.9 
12.7 
5.1 
3.3 
o.o 
I 
9.3 ~ 
9.9 I 5.1 5.9 
I -:1-~-r----1---------l--- ' -
- 1 Orally i I 9 I twice ! 5.0 j 7.2 3-22 13.5 j 7.2 l 22.3 ~ 1 weeldy l 1 I 
t---· Single l ~t~~- i---- ~- 1 ---t~--t---- -
I i 
t ! 
F 
30.9 
l 
~ 10 Injection . 50.0 ! 27.5 18-40 ll.O ~· (. ~ 3.6 
Po I 25.o I 24.5 12-38 12.3 9.4 13.8 0 l 10.0 21.6 6-25 12.4 9.3 25.0 n 1 , 5.o 18.9 3-~6 10.9 8.9 s.3 1 --+- - 1 _ 2.0 10.3 4-15 14.4~ 1 _:o.4 23.1 
· I Inj~
10 j1 twice j1 5.0 ! Treatment stopped after nine weeks - only three pregnant 
8 weekly 5.0 j 65.0 I 5-120j 13.4 9.6 18.7 
*
,_. _ _L2:P ·+ ~8.Q___ ~.,.];3-5_5_ --~ 13. _~_J_ _ 9.1 l---1~._4 __ --+----
control ! 
6 eatments j - l 5.4 l 3.5 - B. 71 12.2 I 9.8 I 14.0 
, (Table 2) , j 
I I 1 
6.6 
11.3 
I 2.5 10.9 j 5.2 
I 
11.5 
13.0 
-
6.0 
0'\ 
"' 
TABIE 7* 
Ef f ec ts of proges t er one on pregnancy and matj.ng i n r ats . 
Data f rom each t ype of administration combined. 
I t , 
I 
j Av. no. days 1 1 between co- J ~ . 
Type ~ ~ habitation i % of mat- } Av. no. jAv. no. of nor-j of f No. 1 and success- ~ ings occur- 1 of C.L. I mal embryos 
Jadmin • . ~ rats :j ful mating. ~ ring in: l (ova) 
l ~ ~ ~ i I l 
~- -,~-~ -r -. " - ···- . ., 
l j J ~ First .First t I J i l i ~ Range f Av. ~ 5 8 l Rang~ Av. ~ange ! Av. j%C.L. ~ j , ~ days . days r l ~ 1 • 
. • I 1 I 1 . I 
. I ~ I l ; u 
~ 
iSingle 
! oral I 
!oral 
!twice 
!weekly 
I 
llsingle t 48 inject-
ion. 
I~ject- j 27 
J.on · 
twi l ce 1 
weekly I 
128.0 
1 to 
65.0 
* Table 7 continued on next page. 
J 
!9.9 187.0 
I ' 9.!~ ~.4 J 8.9 I to l . to 
t 13.0 .1o.3 I 
l 
ij 
~ 
60.0 
1 · 
o.o l 10.9 
to 
12.4 
~ 53.0 
:\ 
1
19.4 ~ 80.0 
~ 
~ 
o.o
2 1 13.4 , 3.6 9.6 19.7 ~ 71. 0 
to to 
13.8 9.7 
Av. no. ova 
unfert. or 
degen. before 
implantation • . 
(% of c.L.) I 
Range i Av. 
3.6 
to 
25.0 
5.0' 
Degeneration 
(% of total 
embryos) 
J I . 
Rang I Av . , %C.L~ 
I . --J 
5.1 1 8.o 8.o 1 
to , ! 
9.9 1 l 
18.7 
to 
19.4 
, 19.o l n.s fl2.3flo.o 1 
:: to ) 1 ~ 
13.o I ~ 
i 
l 
-.J 
0 
TABLE 7 (Cont 1d) 
j j I I I Av. no. days I 
f between co- i l t l habitation 1 % of mat- · Av. no. I A.v. no. of nor-J Type 
I ·~· ~o. I and success- lings occur- , of c.L. mal embryos !rats ful mating. ! ring in: (ova) l ! 
• 
·! l I. j: I I I j · 1 jFirst First ~ Range '% ~ ! j ! Range j Av. 1 5 j 8 Av. Range Av. C.L. ~ ' i 1 ~ 1days days 
I l l 
Control 
treat- 61 l 3.5 5.4 . 65.0 77.0 11.2 12.2 6.6 9.8 8o.o 
ments to to to 
(table 2 8.7 13.7 ll.3 
1. In 25.0 and 50.0 mg. groups, 90% mated after 20th day. 
In 5.0 and 10.0 mg. groups, 6($ mated after 20th day. 
2. In 5.0 mg. group, 75% mated after 40th d~. 
In 2.0 mg. group, 67% mated after 20th day. 
f 
Av. no. ova 
unfert. or 
degen. before l Degeneration I 
implantation. I (% of total t 
(% of c.L.) , embryos) t 
I r l I ! ! ,, ~ 
Range I Av. 1 Range rAv. j%C.L. 
! I 
4 
14.0 1 5.5 o.o 6.0 6.0 
to to 
42.7 15.1 
-l 
1-' 
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TABLE 8 
Average crown- rump lengths of embryos 
of var i ous ages f r om animals treated 
with progesterone. All groups combined. 
Age Av. crown-rump 
No . in Crown-rump lengths in m. m. 
rats days ] 
l 
length in mm. Controls (table 3) 
I Range Av. j 
'j 
1 5 - ' l i l 
' 6 j 
J 
I 7 
- I 
t 8 1 I f 
l q 9 j ~ I - ~ 10 I r r t 1 11 l 8.8 l I I - ' 12 10.0 ~ ! ' ~ 1 ~ 13 10.0 10.7 ~ 
f 
i 1 14 I 11.0 n.o ~ 
I - I 15 13.5 16 15.2 
' 
1 17 18.0 18.5 
18 
1 19 30.0 31.8 
20 
10 21 4o.o-46.o ] 43.1 42.0 
1 
Treat-
ment 
TABLE 9 
Effects of treatment with progesterone 
on mating and estrus in rats. 
Failed to 
Mated twice: mate at first 
second sue- signs of 
estrus.l 
No. of days first full 
estrus delayed beyond 
time expected after 
cohabitation. 
I No. % 
1-=--· ---·-- - - --
5?.0 mg. 1 0/9 o.o . 1/9 · ll.l 1 6/9 j (1-20 days) ! 66.7 i 
, Smgle l l ! (av. 9.0) t l 
!2;::-m;.-1- oM . -o.o·+-6~.o -r- 6/12h6-34 da;>f so.o i 
jSingle ' j 1 1 l (av. 16.0) \ ~ 
1 1~~:mg. - o11it o.o-11--ii/iir-64:9----t---li;i7l·T4~25 days) I 64.9 ; lSingle 1 ! ! (av. 12. 7) ! 04• 9 t \st~~· 1 oFfo.ol-7791 n-.1"-- 7/9 t~ ~~~~ 
1 oral -~ ---~ l l l l i 5.o mg. - j .3/11 !' 27:3_t ____ lii1_J ____ 9.1---~ -- 9!nT c2-33 da;-> 81.9 
' Single j . ! ~ (av. 16.4) 
r;~~c:~n ·o/7 io.o 1 4/7- · -57.2j-6;7f<5-13 daysi 85.8 
!Single I I .. r (av. 9.5) 
0/8 
- w_ e~ __ Y l I r!j~~~d o/9-rO.O - Oi92- 0.09!9 --l<fa~~t~ loo.ol 
twice I ~etly 1 
Total 3/82 3.7 30/82 36.6 62/82 (1-119 days 75.6 
(av. 23.1) 
·--- ---· -·· ~-- --~,---~~-- --~------ : ~~----·-·-- ·-~-----·---·"' ·- ------- -·------ ---t-- -1 
Total 3/60 5.0 11/60 18.7 ll/60 (3-18 d~s) 18.7 
Controls (av. 7.4) 
(table 4) 
1. All animals mated at from second to fifth sign of estrus. 
2. No partial estrus periods occurred fefare mating. 
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TABLE 10 
Effects of administration of progesterone at various phases of the estrous 
cycle on the occurrence of mating i n rats. 
Time of f l 
admini- 1 Average no. of days mating delayed after cohabitation 
stration 
50.0 mg. 25.0 mg. 10.0 mg. 5.0 mg. 5.0 mg. l !1 2.0 mg. 5.0 mg. ~ 2.0 mg. j Control 
Single Single Single Single Single Single Injected · Injected! treat-
oral 1 oral oral oral Injec- Injec- twice twice 1 ments 1 j tion tion weekly weekly (Table 5) 
' r l !:r~ -~0.3 - L_l6.~- -L~~~-_ __::___ __ 32.0 -- __ ::____::_ I - I 6.2 
Estrus j u.o I 4.0 I 6. 7 12.0 15.7 5.0 64.0 )2.8 I . 6.1 
~.-a-.~- U.-c.l~ "'--~t..<t...+---.:-...-!l.,;o"';::o;:.r....,.L.. . ..._.,.,-.:;..,..- r..;;: ..,--., ::..:..J'J-..:.:.o.- .. ~--=--....,. __ ___ ... __,-;-::-_....._...._ __ .. ,._ ~~--~-·---= ,...,.r.s;o!,.r---.~.~ .._,_-....,.:~-__.,'"-f-=-----l 
Diestrus 6.0 16.2 I 12.0 16.8 10.8 ~2.3 68.5 47.2 2. 7 
~------ ~----' -------~----------·----- --
_, 
~ 
TABLE 11 
Effects of subcut aneous administration of 5.0 mg. of progesterone during 
various phases of pregnancy on subsequent reproductive processes . 
Time of in- Av. no. d~ be-
No. ova un-
fert. or de-
I 
l jeetion of I tween cohabitation l Av. no. i Av. no. gen. before j Degeneration I No. 5.0 mg. pro- and successful ·corpora normal implantation. 1 (% total • 
rats gesterone. 
-~ 
f 
i 
• 
' 
~ 
5 Immediately 
after 
• 
mating. 
Range I Mean i 
2-15 ! 8.-6 
lute a. I embryos (% a. L.) j embryos) 
f i b . 
! i ,, ~ l i ~ • 
I. 
ll~.2 9.0 ~ 26.7 13.4 
~ mating l I l ~ I r t """-~~-~t· --"'···~~-r~-~-----'""1·--·-··--·-··-·'i-··-----~-~--t-~"~---·-- -· 
4 1 2 days after 4-9 ~ 6.0 • 14.3 l 8.5 I 33.3 t 10.5 ~{;~:;;- -1~6 _ _L_ql2·:a_j6.s-t-~- 13.i _ _ J 
~0~17--- --;:-;s-;: --,5.4t-~~;.;-·--·- · ·-;.8~- ~~-- -~·-~.~---- r---6~~--
~ea~nts ' I I 
(table 2) · I 
1 
1 j 
I 
i 
a 
~ 
I 
. 
-;] 
V1. 
GRAPH 1 
Effects on mating in rats of graded doses of progesterone given by 
injection and oral administration. 
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Experiments on the administration of anhydro-hyctroxyprogesterone: 
Mating and pregnancy. The experimental results presented in Table 12 
show that administration of various dosages of anhydro-hydroxyproges-
terone orally or by injection had nomverse effect on fertilization and 
implantation. It is also obvious that there is no regular difference 
beuveen the effect of injection and oral administration on the occurrence 
of mating. This can be seen more clearly if the data in Table 13 in 
which average values obtained from the combined groups receiving various 
types of administration are compared with average control values in 
Table 2. The table further shows that treatment had no effect on the 
number of ova produced, the percentage of ova unfertilized or degenerated 
before implantation, or the development of the embryos once implantation 
had occurred. 
Table 7 shows that in the animals receiving oral administration 
there was no notable proportionality between dosage and dellzy" in mating. 
If one considers the mean delay for mimals receiving 2 to 50 mg. in a 
single oral dose the mean delay of 9.4 ± 0. 920 days is significantly 
different from t.1-!e mea.Tl. of all controls (5.5 ± 0. 760). However, as can 
be seen, the effect of anhydro-hydroxyprogesterone on matings is slight. 
It is somewhat surprising that twice weekly oral administrations of 
25 mg. did not result in a significant delay in mating. It is also true 
that the data on the delay of mating after the subcutaneous injection o£ 
anhydro-hydroxyprogesterone do not differ significantly from fuhe control 
values. 
The average crown-rump lengths of embryos of various ages from ani-
mals treated with anhydro-hydroxyprogesterone are presented in Table 14. 
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The table shows tha. t the various types of administraticn of anhydro-
hydroxyprogesterone had no notable effect on embryonic growth when 
values are compared with those from controls in Table 3. 
ltia ting and estrus. Table 15 presents more data from the records of 
vaginal smears on the effect of anhydro-hydroxyprogesterone on mating 
and estrus. In general, the incidence of unsuccessful matings was no 
different than those in control groups. The failure of mating to occur 
at the first signs of estrus was apparent in all groups, but the per-
centages of animals in which this occurred was on the average of twice 
as high in the orally treated groups as in the injected groups. The 
average for the injected groups was c:bout 19.2 percent which is similar 
to the 18.7 occurring in control animals. However, the average percen-
tage in the orally treated groups was about 37.9 percent. In all groups, 
but those receiving 10 mg. by injection, only partial estrus periods 
were noted before mating took place. It is thus indicated that orally 
administered anhydro-hydroxyprogesterone partially inhibits estrus. 
Table 15 further shows that although the percentage of animals in 
which full estrus was delayed beyond the time it would normally be ex-
pected after the males were in traduced, in the orally treated groups the 
delay was on the average longer than in the injected groups. This again 
points out the relative effectiveness of the various types of adminis-
tration of anhydro-hydroxyprogesterone. 
Relation between time of administration and occurrence of mating. 
Table 16 shows the effect on mating of various types of administration 
of anhydro-hydroxyprogesterone in different periods of the estrous cycle. 
It is clear that no consistent differences occurred lfihen treatment was 
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given in early estrus, estrus, or diestrus. 
Microscopic examination of ovaries and uteri from animals treated with 
anhydro-hydroxyprogesterone. Figure 11 shows a section of an ovary takm 
from an animal 29 days after a single oral dose of 50 mg. of anhydro-
hydroxyprogesterone. The animal was not pregnant at the time it was 
killed. The ovary appears to be very active with large numbers of 
grmving and mature follicles. Although the animal had not mated for 
29 days, ovulation was about to occur when it was killed. Since other 
animals treated in the same manner mated in from 1 to 44 days, it is 
possible that the effects of the treatment were wearing off and that 
the animal was about to mate and ovulate at the time of killing. Figure 
12 shows a section of the uterus from the same animal. In general, it 
is similar to the uterus from an cnimal in estrus (Figure 6) except 
that there is no distension and the relative endometrial thickness is 
two to three times as great. 
Figure 13 shows the ovary of an animal killed 19 days after a 
single oral dose of anhydro-hydroxyprogesterone. The ovary appears 
similar to that of an animal in diestrus (Figure 1). No Graafian fol-
licles are present. Figure 14 shows the uterus of the same animal. It 
is similar to that shown in Figure 12 except that the endometrium is 
somewhat thicker. 
In general, the effect of orally administered anhydro-hydroxy-
progesterone on the ovaries and uterus appears to involve the inhibition 
of follicular maturation. This treatment f'urthar appears to cause a dis-
tinct proliferative effect on the endometrium. Data from vaginal smears 
support the idea that oral treatment with anhydro-hydroxyprogesterone 
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induces a condition similar to diestrus which persists for much shorter 
periods than after treatment with progesterone. 
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TABLE 12 
Effects of various dosages and methods of administration 
of anhydro-hydroxyprogesterone on pregnancy in rats. 
l Days between co- Ova unfertilized I ~ habitation and Average Average or degenerated Degener-~~ 
Treatment successful no. of no. of before ation 
No. Dosage mating corpora normal implantation (% total 
rats Method (mg. ) Mean Range lutea embryos (% of C .L.) embryos) 
Single ~- - - ~ 
20 oral 5o.o 10.6 1--lth 11.8 10.2 1 5.6 
16 1 25.0 8.8 1-32 12.2 10.9 1 1.2 i ~ 20 I 10.0 8.4 I 1-28 11.7 10.5 l 4.3 1 I 16 i 5.o 9.5 1 1-25~ 10.7 10.4 1 o.6 I ~ 16 i 2.0 9.6 1-28 10.1 9.5 ! 1. 9 ! 
. ~~L-~-----l_-___ }:_~?~~l-~-~~~~-__2--~~ --~-~-----~~---+-~~-~~.!:._-~~ , 
I I Oall I i ! I l . ' r y ! 1 f 12 j once 1 25.0 7. 7 I 1-23 I 11. 8 1 9.1 I 13.5 ! 
. ~-~--t---1- ··--~--- . ----~----~--1---~-~-- ------~L-- - i 
12 1 injection l 5o.o I 5.3 I 1-9 11.6 j 9. 9 7.9 l 7 .o I 
10 ( 25.0 I 10.1 I 0-21 10.4 l 6.6 15.1 l 24.1 : 
12 I l 10.0 6.5 1-25 12.1 I 8. 7 l 9.0 l 21.2 . 
:il: ~~=~ 3.5- 8.7 12.2 l~-- ~~-;-·t-·--JJ,.~--1 - · 6.0 
(Table 2) ~ I 
1 
I I 
8.1 • 
4.4 ' 
J 5.8 
2.4 I 3.8 
15.6 ~ j 
~ 
~ 
10.7 l • 
CD 
f-1 
• 
l Type 
of 
Admin. 
! Single 
$ oral I 
t 
~ Orally 
l once 
! weekly 
i . i Single 
~nject-
ion 
i Control 
treat-
ments 
(table 2 
}No. 
1rats 
. 
1109 
I 
12 
34 
61 
TABLE 13 
Effects of anhydro-hydroxyprogesterone on pregnancy and mat:in g in rats. 
Data from each type of administration combined. 
· Av. no. days 
between co- 1 i 
habitation i % of mat- J 
and success- ~ ings occur- , 
ful mating. l ring in: 
Range I Av. 
.• ~ 
·~ 8.2 
to 
10.6 
~ 
l -I 
'· 
5.3 
to 
10.1 
" I -
I 
I 
i 17.7 
s 8 i First. ,First 
Days Days ! 
~45.o 56.o i ~ I L 
. 4 
. ~ i l ~ l l I 
I I I 
6o.o 175.0 J 
r 
I . 
53.0 i7l.O I , 
3.5 
to I 5.4 l65 •. o t77 .o 
8.7 
I l 
Av. no. !Av. no .. of nor-
1 
of C. L. ! mal embryos . 
(ova) · l 
....1-..------~_j 
Av. no. ova 
unfert. or 
degen. before 
implantation. 
(% of c.L.) 
Degeneration 
(% of total 
embryos) 
~ ~ r l ! i Ran Av. !Range v. ~.L. t Range ~ l 1 • I 1 ~ • I Av. 1 Rang; Av. ~%C.L.I 
10.1 n1.4 j 9 .. 3 ~o.~ 88.o 
to J 1 to 
12.21 ! 1o.~ I i 
l l 
I \ 
- 6.8 j - l 9.11 11.0 
i 
o.6 
to 
9.4 
I j 
10.4 f11.4 l 
to I I 
12.1 , l 
6.6 i 8.4 74.0 !_ 7.9 
to 1 1 to 
6.9 ) I 15.1 
I 
l ~ 
ll.2 I~ I 6.6 I to 2.2 to 9.Bj8o.o 
13.7 , n.3 I 
5.5 
to 
42.7 
l 
! 5.0 
l 
) I ~ ~ 2.4 j 7.0 ~7.0 
~ to i . i . l 
t 15.6 i i 
l 
r 1 I , 
113.0 i 1 ~ ~ 
- fn.o!lo.o f I I l . . j ' 
j ~ 
i n.o I 7.0 jl7 .o l15.o 
J r to ~ 1 
J I 24 .. 1 ' · 
14.0 
o.o 
to f 6.0 
15.1 
6.0 
i 
l 
~ 
J 
f 
co 
1\) 
~ I 
~ 
! ~ 
~ . 
~ ~ ~ 
~ f 
i 
I 
I 
I 
~ 
i 
I 
I 
TABlE 14 
Average crown-rump lengths of embryos of 
various ages from animals t r eated with 
anhydro-hydroxyprogesterone. All groups combined. 
Age Av. crown-rump 
No. in : Crown-rump lengths in m. m. 
rats · 
! 
-
-
-
' 
1 
- t 
- I 
- I 2 j 
3 .~ I 12 
4 I 
days , 
i 
5 ' 
., 
I 6· 
7 i I 8 I 9 
10 
11 
12 
I 13 
' 14 I 15 l, ~ 
f. 
16 I ~: I 
19 f l 
20 
21 
length in mm. 
Range 
-
-
-
-
-· 
-
' 
-
8.o-1o.o 
n.o-14.o 
10.0-13.0 
12.0-14.0 
15.0-17.0 
18.0-22.0 
22.0-30.0 
31.0-35.0 
33.0-31.0 
38.o-44.o 
j 
' i ! 
' I i 
I 
. 
i 
I 
I , 
I 
• I 
l 
Av. 
-
-
-
4.0 
-
-
-
9.0 
12.3 
ll.2 
12.8 
19.1 
24.1 
33.0 
35.3 
41.5 
pontrols (table 3) 
-
-
-
-
-
-
8.8 
10.0 
10.7 
11.0 
13.5 
15.2 
18.5 
31.8 
42.0 
' 
I l 
i 
I 
i 
t 
I 
I j 
I 
Treat-
ment 
Total 
TABLE 1.5 
Effects of treatment with anhydro-hydroxyprogesterone 
on mating and estrus in r ats. 
Failed to 
Mated twice: · mate at first 
second sue- signs of 
1 
l 
cessful. estrus. 1 
No. of days first full 
estrus delayed beyond 
time expected after 
cohabitation. 
11/146 7 • .5 ·. .52/146 3.5.6 80/146 (a-43 days) 54.8 
(av. 10.9) 4---·-+--~-- r- -·~·-1----·'7:------·--- ·- r------- ---::-----::-t-----1 
Total 3/60 .5. 0 ll/60 18.7 ll/60 ~3-18 days) 18.7 
Controls (av. 7 .4) 
(table 4) 
1. Matings took pl ace from second to third sign of estrus. 
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I, Time of admini-1 stration 
TABLE 16 
Effects of administration of anhydro-hydroxyprogesterone at various phases 
of the estrous cycle on the occurrence of mating in rats. 
Average no. of days mating delayed after cohabitation 
ll ~o.o mg. j25.o mg. ,. lo.o mg • . , 5.o mg. pingle f3ingle . Single Single I oral 1 oral 1 oral 1 oral 
J j I 
2.0 mg. 1.1.0 mg. II. 25.0 mg. 
Single ,Single . orally 
oral I oral f once 
!25.o mg. 11o.o mg. 
Single Single 
Injec- Injec-
l lweekly tion tion 
r-- l ; I I I -j Early ! 12.3 I 5.6 6.6 16.2 7.4 I 9.3 I 3.0 I 7.0 1 6.0 
Control 
Treat-
ments 
(Table 5)' 
6.2 
Ff- 1 j l j__j_ ' ~ -L ·:_::-j;.l~ -:~:~~ ~~ --~~L.~-~~.:_:__l_5·~-~-~ 6.1 I 
Diestrus I 13.0 a.o 9.4 4.9 12.6 6.8 9.0 15.0 6.7 2.7 
Q) 
\J1. 
Exper iments on the administration of 17-methyl progesterone: Mating 
and pregnancy. Table 17 presents tre data obtained from experiments 
in which female rats were treated with oral, subcutaneous end intra-
vaginal administrations of 17 methyl progesterone. The data show that 
the various types of treatment had noadverse effects on fertilization, 
implantation, and development when they are compared with data from 
cont rol animals. Table 18 shows this more clearly as average values 
from groups receiving various types of administration of 17-methyl 
progesterone can ·rbe compared with the average control values in Table 
2. It thus can be seen that once mating and ovulation occurred, treat-
ment had no consistent effect on the number of ova produced, the per-
centage of ova unfertilized or degenerated before implantation, or the 
development of the embryos once the ova became implanted. Although 
single oral administratiozE appear to have had slightly adverse effects 
of fertilization, implantation, and normal development because of the 
proportion of ova unfertilized or degenerated before implantation 
(21.0 percent compared with 14.0 percent in controls) . and the degenera-
tion after implantation (12.0 percent co nipared with 6.0 percent in con-
trols ), the differences are not statistically significant. 
On the ot her hand, Table 17 shows that the types of treatment used 
had very different effects on the occurrence of mating. It is .quite 
obvious that subcutaneous injection is far more effective than oral or 
intravaginal administration in delaying the occurrence of mating. The 
aver age intervals between cohabitation and mating in groups given s ingle 
oral doses of 2 to SO mg. were slightly longer than in the contr ol 
groups (means, 6.8 versus s.4), but these differences are not statistically 
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significant. This lack of effect is confinre d by the data in Table 18 
which shows that in groups given 17-methyl pro gesterone orally 75.0 
percent of the matings took place in the first 8 days as compared with 
77.0 in the controls. Administration of 5 mg. orally twice weekly was 
without effect, the average delay of mating being 4.7 d~s vnth 82.0 
percent of the rats mating during the first eight days. 
Single injections of 5 to 50 mg. of 17-methyl· progesterone were 
very effective in prolonging the interval between cohabitation and 
mating. Injections of 50, 25, 10 and 5 mg. prolonged the average inter-
vals 35, 23, 3 and 2 days respectively beyond the longest average inter-
val in the control groups (8.7 days). Injections of 2 mg., however, 
were without obvious effect. The effectiveness of injected 17 -methyl 
progesterone was apparently related to the dose administered. Graph 2 
presents the dose-response relationships of orala> compared with sub-
cutaneous administration. A clear dose-response relationship can be 
seen with injection while no such relationship exists with oral admini-
stration. The effectiveness of injected 17-methyl progesterone is also 
of long duration because 78.0 percent of the matings took place after 
40 days in the 50 mg. group, 66 percent af'ter 30 days in the 25 mg. 
group, 58.0 percent after 11 days in the 10 mg. group, and 55.0 percent 
ai'ter 13 days in the 5 mg. group as compared with 77 .o percent in the 
· first 8 d~s in the control groups. Although injections of 2 mg. once 
weekly prolonged the interval between cohabitation and mating roughly 
twice as much as a single injection of the same dose, twice weekly in-
jections of 2 and 5 mg. were much more effective . As with progesterone, 
with this type of administration the possibility of inhibiting mating 
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indefinitely was indicated. This was particularly true of the group re-
ceiving 5 mg. twice weekly. While in the 2 mg. group all animals had 
mated successfully before the seven week administration ~s stopped, in 
the 5 mg. group all mated 9, 12, 15, 38 and 64 days respectively (av. 
24.3) after the treatment was stopped. Again as in the animals given 
repeated injections of progesterone, it is indicated that an adaptation 
of the ovulatory mechanism to the 2 mg. inhibitory level takes place 
permitting ovulation to occur in spite of continued administration. 
With 5 mg. treatments this adaptation mechanism is either inhibited for 
much longer periods or indefinitely. 
Table 18 shov1s that, although there was an effect on mating, single 
or repeated injections of 17-methy1 progesterone had no effect on subse-
quent reproductive processes after successful mating had taken place. 
If values in Table 19 are compared with values from control animals 
in Table 3, it can be seen that no type of treatment with 17-methyl 
progesterone interfered with embryonic growth after implantation. 
Although by inspection of rable 17 it may appear that vaginal ap-
plication of 10 mg. of 17-methyl progesterone was effective in delaying 
the occurrence of mating, the number of animals employed was insufficient 
to establish a statistically significant effect. It is obvious that 
there was no significant effect when 2 and 5 mg. were a,_oplied to the 
vagina. 
Mating and estrus. Table 20 presents more data concerning the effect of 
treatment with 17-methy1 progesterone on mating and estrus. The occur-
rence of unsuccessful matings was obviously no different than that found 
in control animals. However, the occurrence of partial estrous periods 
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during which the male was not accepted occurred in a higher percentage 
than in control animals. In all cases except one in which animals did 
not mate until the second to fifth estrus, all estrous periods were 
partial until a full estrus and mating occurred. Those animals which 
received a single injection of 50 mg. 17-methyl progesterone had no 
evidences of estrus until mating occurred. This dose was also the most 
effective of the single injections in delaying mating. In animals re-
ceiving repeated doses, even though the delays in mating were more pro-
nounced, partial estrus periods did occur before mating. In these 
animals estrus also occurred irregularly. Table 20 also shows the per-
centages of animals in which full estrus, 'Which is indicated by accep-
tance of the male, was delayed beyond the time it was first expected 
after the males were introduced. In the orally treated animals 18.2 to 
57.6 percent had delayed full estrus while the percentages were 54.6 to 
100.0 in the injected groups. Also the average delays were longer in 
the injected groups. 
Relation between time of administration and the occurrence of mating. 
Table 21 presents data on the effect on mating produced by the admini-
stration of 17-methyl progesterone during various phases of the estrous 
cycle. It is obvious that no regular differences occurred in any of the 
types of treatment. 
Effects of administration of 17-methyl progesterone at various times . 
during pregnancy. Since the injection of 17-methyl progesterone produced 
so marked an effect on mating and estrus, experiments were performed with 
small numbers of animals to find whether small doses injected at various 
times after a normal mating would have any effect on subsequent 
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developmental processes. Table 22 presents the data from these ex-
periments. Control values for each experiment in the series were 
taken from the other experiments in the series and also from the values 
lis ted in Table 2. 
In the first group, 5 mg. of 17-methyl progesterone was injected 
subcutaneously into. animals immediately after mating. This was done 
in order to test whether the progesterone would inhibit the transport 
of spermatozoa and thus prevent fertilization or cause degeneration 
of fertilized ova in the Fallopian tubes. It is somewhat surprising 
that vmile fertilization and ovum degeneration did not seem to be af-
fected, 33.8 percent of tbe embryos which became implanted degenerated. 
Since the animals were injected even before implantation took place, it 
must be assumed that the effect of the 17-methyl progeste~ne was either 
delayed until after implantation or was specifically concerned with em-
bryonic development. 
The second experiment in which 17-methyl progesterone was injected 
two days after mating was performed to test the effect on implantation. 
The data show that there was some effect on implantation since 23.1 per-
cent of the ova ovulated were unaccounted for. Although these data con-
tradict the explanation of the results in the first experiment, an ex-
planation is difficult to make. 
The results of the third experiment were, however, clear. This 
experiment in which injections of 5 mg. of 17-methyl progesterone were 
given on the 13th to 18th days of pregnancy was designed to test the ef-
fect of the injections on the degeneration of the embryos. The results 
show that all values fall within control limits except the percentage of 
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embryonic degeneration. This percentage vms nine toten times that 
found in control animals (Table 2) indicating that small doses of 17-
methyl progesterone have a severely adverse effect on 13 to 18 day old 
embryos. 
Microscopic examination of ovaries and uteri from animals treated with 
17-methyl progesterone. Figures 15 and 16 shovr sections of ovaries taken 
from non-pregnant animals 59 days after a single injection of 50 mg. and 
the first of a series of 2 mg. injections of 17-methyl progesterone given 
twice weekly respectively. In general, both of the ovaries are similar 
to those from animals in diestrus (Figure 1). While inunature and growing 
follicles are normal in number, no Graafian follicles are present. 
Figure 17 shows a section of an ovary taken 47 da;rs after a single 
injection of 17-methyl progesterone. The general appearance is similar 
to that of the ovaries shown in Figures 15 and 16. No Graafian follicles 
are present. Figure 18 shows a section of the uterus from the sane 
animal. The uterus is similar to that of an animal in diestrus (Figure 
2) except that the lumen is somewhat smaller and the endometrium is 
about twice as thick. 
These figures clearly show that injection of 17-methyl ~rogesterone 
induces a condition very similar to diestrus. Data from vaginal smears 
support this conclusion. The effect on endometrial proliferation is 
also very marked. 
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No. 
rats 
20 
21 
11 
11 
I 
TABLE 17* 
Effec~s of various dosages and methods of administration of 
17- methyl progesterone on pregnancy in the rat. • 
D between co Ova unfertilized 
Treatment ~ 
Dosage 
----•o ---.--- ---- - -- ___ .L ____ ------ ,,- -- --~ 
Method (mg.) Mean Range lute a embryos (% of C.L.) embryos ~ 
Single I 50.0 1.6 I 1-20 12.1 . I 9.1 16.4 10.3 1 
oral I 10.0 6.9 1-34 12.o 9.5 12.3 1o.o I 
! 5.0 6.0 I 1-23 11.7 I 7.5 26.4 12.6 & 2.0 
l ~r-1:~- ~-----:s::. J 
~ OrallT I twice 5.0 4.7 1-14 I 13.1 . 11.0 
• 9 ,-· =~ I ~o.o 43.5~-52 ·-r-11~ 10,;----l I 6 injection l 25.0 j 31.3 I 21-40 1 12.0 1 10.2 1 12 I 10.0 I 12.0 6-21 . 11.8 . 9.6 i l ' . i ! 10.9 ~ 
11 weekly 2.0 27.4 7-49 . 12.6 I 9.4 9.4 18.2 
l 1 
I I 
*Table 17 continued on next page . 
'0 
I\) 
No. 
rats 
6 
6 
4 
61 
TABLE 17 (Cont1 d) 
Days between co-
habitation and 
Treatment successful 
Dosage mating 
Method (mg.) Mean Range 
Average 
no. of 
corpora 
lute a 
Average 
no. of 
normal 
embryos 
Ova unfertilized 
or degenerated 
before 
implantation 
(%of C.L.) 
Degener"""• 
at ion~ (% tot . 
embryos' 
Single 
1 
1;.0 -~ 13.2 ~ --- -J~3l-- r -- {3.2 --~-9. '7 l 12.9 ~ 6.5 
in~ra- 5.0 I 7.5 I 2-12 1 14.3 1 10.3 1 11.6 18.4 ~!1 -r-0 1·-;.~~' 3 : ·r-~~  · ---;.~--· 
treatments · · ' I 12 · 
(Table 2) 
'I) 
\),) 
r 
Type 
of 
admin. 
TABlE 18* 
Effects of 17-methyl progesterone on pregnancy and mating in rats. 
Data from each type of administration combined. 
l .. -- r Av. no. days I --l--- --- f Av. no. ova ,~ : 
between co- ; unfert. or § 
j I habitation % of mat- . l Av. no. . :v. no. of nor- f. degen. before Degeneration 1 j No. I and success- ings occur- l. of C.L. 1 mal embryos l implantation I (% of total. ! 
1 rats fu1 mating ring in: f (ova) j ~ (% of C.L.) ~ embryos) i 
l . . -~ - - ---- .~ --- ~- -- ~ - - -- . -- > . ! 
r~r I !First First . i l ~ j ~ . r -~ 
I Range Av. I 5 8 Range Av. ~ Range Av. rl%C.L. ( Range ! Av. ! Range Av. ~.r,.~li 
I J I jctays days ~ ! ~ ! l 
:Single .163 6.o J 6.8 j65.o 175.o ln. 7 12. ?t.· 7 .5. ~ 8.6 1 68.0 !' 12.3 f 21.0 11o.o .12.0 11.d 
oral j J to i I ! to 1 ~ to ~ to j l to j . ! 
i I 7.6 L ·--~ ~ - _ _1_ ___ 1_1?_·6 I J 9:~.1~-- ~. _L _29.? J. i 15.1 1 t I 
jorany Jn ,. - l 4.7 '64,o I ~ ~.· - T13.11 ----r1.oTI ai..OT_:-_ ! 9.7 1 --:--Ta:cl~· 6.ol.; ~ twice ~ I I 1 I ( J ~ I ' l ) weekly ~ I :. ____ L ___ L_ L ___ L_ 1_ ___ l ~ I . _l : j 
fsingle '· 5o . J 7.3 J· - j2 mg. I 1. 1. 9.9 Jn.2 8. 7 ( 9.6 j 86.o I 8.o. b l.o ~ 6. · Of'i s.q 
J inject- ., i to f grp. I 1 to ! to . I ~ . to. I ~ l ~ ion I 1 43.5 i j66.o j 12.0 I 10.3 · i __ · 13.:.~j ___ } 1 
~. Inject- f 1o-l~-- l l5.L:-[ :.: -- ~ ~2-. --r - ln.4 - 8.s j 7B.o 1·. - :... ., •.. i5.8 1 --=- .,-s-. q 6.a .·
l . I l I • t 1 
• ion I I . l I i t II l ! 
. once . I j r ! ~ i i 
· weekly l I · I I f I f I J I 
Inject- 117 
ion 
twice 
weekly 
f I I I I I . ! 27.4 t - · - 3. 12.6 12.7 9.3 9.L. 74.o 9.4 12.0 12.5 16.d 14.q
to J I to to I to to I 
69.2 I I 112.7 9.4 .. J 15.8 18.2 
* Table 18 continued on next page. 
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TABLE 18 (Cont 1 d) 
I Av, no, days I · { ~ Av. no. ova I I between co- • ~ un.fert. or 
Type 1 ! habitation r % of mat- Av. no. ~v. no. of nor- degen. before Degeneration 
of ~o. I and success- lings occur- · of c.L. mal embryos . implantation (% of total 
admin. h-ats ful mating f ring in: (ova) (%of c.L.) embryos) 
I [First !First 1 ( ~ I %C.L. I Range ~.L. 1 Range j Av. J 5 I 8 l Range Av. Ran~1 Av. Av. I Range Av. da}ra 1da_ys J · · j ~ i - j5 &lo 1 4. i 12.s t; 7 ~0.4 • 11.o j 2.4 9.o 1 11.~ ~ p.6 4.5 3.4 I 78.0 i 9.8 ~ Intra-vaginal 1 1~2 mg. ~ J to i to I to j ! 12.9 t grps. t i 14.3 11.3 
I ~ 5o.o 1 l 
2 mg. ! I grp • . 
75.0 
3.5 5.4 65.0 77.0 11.2 2.2 6.6 Control r treat- to to to 
ments 8.7 13.7 
_,n_.J (table 2 
_, __ - - _ __ . L_________ __ ~ L_ -- -
1. In 50.0 mg. group, 78% mated after 4oth day. 
In 25.0 mg. group, 6Cfl, mated after 3oth day. 
In 10 mg. group, 58% mated after 11th day. 
In 5.0 mg. group, 55% mated after 13th day. 
2. In entire group, 60% mated after loth day. 
3. In 5.0 mg. group, 1<>0% mated after 50th day. 
In 2.0 mg. group, 73% mated after 2oth day. 
9.8 
- - -
4. In 5.0 and 10.0 mg. groups, 50% mated after loth day. 
18.1,. 1 l 
J 
f I I I I 
ao.o 5.5 14.0 o.o 6.c 6.o 
to 
I 
to 
- 1_ 42.7 15.1 
--- - '---
"' \.11. 
! 
I ! 
' 
No. 
TABlE 19 
Average cro>Wl-rump l engths of embryos of 
various ages from animals tre ated with 
17-;·nethyl progesterone. All groups combined. 
I ! Age I Av. crown-rwnp Crown-rump lengt hs ll1 m. m. 
r ats 
i n j 
days ! length in mm. Controls (tabl e 3) 
I 
' f ! 
Range 
I 5 l . - -I 6 
-
l I 
-
I 
f l I 
1 7 l -
' 1 8 • 
-
I t ! 
1 9 
1 10 
6 11 8.0-9.0 
5 12 5.0-10.0 
8 13 10.0-12.0 
7 14 9.0-15.0 
14 I 15 13.0-16.0 10 16 15.0-16.0 
6 17 15.0-20.0 
6 18 25.0-26.0 
3 19 25.0-30.0 
2 20 35.0-36.0 
1 21 
! 
i 
i 
J 
I j 
Av. 
-
-
4.0 
4.0 
5.o 
6.0 
l 
-I -
I -
.I 
-
8.8 
8.2 10.0 
10.5 10.7 
12.3 11.0 
14.1 13.5 
15.3 15.2 
18.5 18.5 
25.2 
28.3 31.8 
35.5 
40.0 42.0 
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I 
Treat-
ment 
TABLE 20* 
Effects of treatment with 17-methyl progesterone 
· on mating and estrus in rats 
'Mated twice: 
second suc-
cessful. 
No. % 
Failed to 
mate at first 
signs of 1 estrus. 
No. % 
No. of days first full 
estrus delayed beyond 
time expected after 
cohabitation. 
No. (Delay) % 
56.0 mg. 0/21 0.0 5/21 24.0 l 12/21 (2-18 days) 57.6 . 
r-':-:-.:-1m~e g-.--+- 0-/2-0 -h:~--+---7;~-- 35.~i--;/2~ (~=~ :~ 
Single j (av. 12. 7) i 
oral ·--~-- --- ---~·-·-- --·--·-- --·--------r· -·-~------. -- ~ 
5.0 mg. I 1/11 9.1 2/11 18.2 2/ll j(8-21 days) 18.2 
Single \ 'I ~ (av. 14.5) 
oral · · _L 
2,0 ;:---r· 1/ii- 9.1-· ~~o;:li-r-1 o.o+l· ·-2/n T<4-13 days) 18.2 
·Single . · (av. 8.5) 
ll' ;~::g. --ro;lO ·a;·o- ·--.3/102- 3 o. o · -io.1-0 o2-51 ~floo. 
Single . I . (av. 43.8) t 
~~c:::n ·2 112! 16:7 ___ 9/12 75.o--.. ---Ui2/i2 . <2=18 -d:~y;)lioo;D 
1single (av. 8.1) . 
' Injection 
f 5.0 mg. 
·Single 
Injectioi.:... 
2.0 mg. 
Single 
Injection 
0/11 o.o 3/11 
* Table 20 continued on next page. 
_, .. _.....;::....,._ ,_____.. __ ,.-.:._..._. -- --- -+---
27.3 10/11 (2-10 days) 91.0 
(av. 8.5) 
- --t=-·-·-.-"""' ....... .__. - -- --
9/11 (2-18 days) 81.9 27.3 
(av. 6.8) 
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TABLE 20 (Cont'd) 
.! 
I Failed to No. of days first full Mated twice: mate at first estrus delayed beyond Treat- second sue- signs of ' time expected after 
ment cessful. I estrus. cohabitation. 
No. % No. % No. (Delay) % 
! 2.0 mg. 2/11 118.2 I 5/11 45.5 ~ 6/11 i (3-26 days~ 54.6 I !Injected l f (av. 11.2 I once I 
-t . 
·--··-·-··---1 ~ weekly --· -·-·--- ,..... .. - ----- -~-· . -· r---·-------·~-·-·· 
2.0 mg. 0/11 o.o 9/11 81.9 ll/11 (3-45 days) 100.0 
·Injected ·. (av. 24.5) 
twice 
weekly l 
Total 6/141 4.3 49/141 34.8 88/141 (2-57 days) 
(av. 14.9) 
62.5 
-· 
-···--- .............. ~-· ,.. ... ~-.... ._....,.._.._.,._ ---..... --. .....-- • . 11' .. ...,..,_ .... ~.-· .. · ' _.. ....... ,_,~ ..... .............. ,-_,., ..... ,.. ._,\. .. ...... __ 
Total 3/60 5.0 11/60 18.7 11/60 (3-18 days) 18.7 
Controls (av. 7.4) 
(table 4) 
1. All mated at from second to fifth sign of estrus. 
2. No partial estrus periods occurred before mating. 
3. One trip1r mating; third successful. 
TABlE 21 
Effects of administration of 17-methyl progesterone at various phases 
of the estrous cycle on the occurrence of mating in rats. 
Time of 
admini-
strationj 
to.o mg~lo.o mg. 
~ingle jSingle 
oral ~ oral 
I 
Early I 9.8 I 9.0 ~ 
Average no. of days mating delayed after cohabitation 
oral j oral twice injec- ' injec- injec- Injec- l tion tion 1 ments 
5.0 mg. J 2.o mg. i 5.0 mg.rO.O ~g.J lo.o mg. 5.0 mg~ 2.0 mg., 2.0--mg 2.0 mg. ~ Control 
Single ~. Single · Orally . Single : Single Single. I. Single Injec- Injec- i treat-
J. weekly 1 ti~ I . tion_ .. tion .. tion I >1eO::~y ~~ I (Table 4 
~ i l I f I I j - ~ 
estrus 
Estrus - ! 12 .o . 1 12.6 
~; 
-= 
4.8 ~ 8.3 l 10.0 47.0 11.4 : 12.2 I 8.7 7.5 31.8 ! 6.2 ~ 
1 
•- · ! - ~-4.~+--;:7 · -~ ~-:;-1~;;:;1 3.;·}3:; r6.~ ---+----i__j___:·_ - --- -~~-~--- ____ -~_p__ . : 
Diestrus I 7.1 I 6.4 1.2 I 3.3 I 3.6 I 47.3 I 1o.o 112.3 I 8.7 114.8 1 21.3 I 2.1 
\.0 
\.0 
TABLE 22 
Effects of subcutaneous administration of 5. 0 mg . of 17-methyl progesterone 
during various phases of pregnancy on subsequent repro ductive processes. 
I I I I No. ova un- j I j Time of in- I Av. no. days be- j fert. or de- I I 1 jection o:f 1 tween cohabitation J Av. no. Av. no. gen. before I I No. I 5.0 mg. pro- J and successful I corpora normal implantat ion I 
1 rat s I gesterone. l matin~. j lutea embryos j (% c. L.) 
l i 
I ! J ~ ; ~ l ~ Range I Mean • I I I ~ i i I ~ I 
; l ! f 
,! 
Degenerati on . 
(% total 
embryos) 
-
t J f ; -I J.-~J 11 H.7 1 12.o i 1.1 1·• , I 1 arter I 1 . i ~ 
, I mating I ! · 1 ~ I t f 
r-13· ·1.2 d;:-:r. ter +-
1 
~. ·;_7 -~~~·.·-;;.2·-~11.;--r.· -~. -z;-r--~-23-:~-. - 22.1 i 
I I mating ~ -t i ~ ~;1-13-~:F"r·-;:;;~-,~;2_;- -, -~.;- I ---4.;-- ,-~6~;---~ - 55.4 , 
~:;: -~--r;-:5..s:;--15J:-r-;:;-:;--··-r-·-;:a··-r-·- --;J:-~~·--·-r·-- ~~ · · 
treatments 
(table 2 ) 
b 
0 
GRAPH 2 
Effects on mating in rats of graded doses of 17-methyl progesterone 
given by injection and oral administration. 
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Summar;x: of the effects of progesterone and related compounds on the 
occurrence of mating. The results of the present investigation re-
vealed that tre administration of progesterone and related compounds 
before mating inhibits the occurrence of es t rus an::l ovulation for from 
a few days up to 35 days or more without affecting fertilization, im-
plantation, or normal development of the embryos. The effects of these 
compounds on the occurrence of estrus and ovulation in terms of the 
time interval between cohabitation arxi successful mating are summarized 
in Graph 3. It can be seen that: (1) progesterone and anhydro-hydro-
xyprogesterone are relatively effective orally as compared with 17-
methyl progesterone; (2) progesterone and 17- methyl progesterone are 
quite effective by injection; (3) twice weekly injections of small 
doses _of progesterone or 17-m.ethyl progesterone most effectively 
inhibit estrus and ovulation. 
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__ GRAPH 3 
Effects of various cbsages md types of administration of progesterone, anhydro-hydroxy-
progesterone and 17-methyl progesterone on mating in rate. 
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a 
DISCUSSION 
Although the inhibitory effect of orally administered progesterone 
on mating and estrus is statistically significant, it is but a slight 
one of very short duration (3 to 4 days). Since the eff ect of injected 
progesterone is marked, it must be assumed that an inactivation of the 
orally administered honnone occurs. Recent work has shown that such 
inact ivation does occur in the liver (220,221,321). Masson and Hoffman, 
(321) actually found that 0.5 mg. of progesterone administered sub-
cutaneously caused approx:ilnately the same degree of endometrial response 
as 200 mg. administered by gavage. Therefore it is very likely that a 
simil ar inactivation took place in the present experiments. 
Injection of progesterone, however, shows a marked inhibitory effect 
on mating and estrus and is of longer duration, up to 19 or 20 days. 
Furthermore, treatrrent with single injections of progesterone shews a 
clear dose-response relati onship with the maximum response occurring in 
the range of 2 to 10 mg. Di fferences in the degree of effect with lower 
and higher dosages may possibly be explained in terms of differential 
rates of absorption. 
A1 though with repeated injections of 2 mg. mating and estrus is 
inhibited for relatively long periods, eventually successful estrus, 
mating and ovulation do occur in spite of continued administrations. In 
general, vfith repeated injections of 5 mg. the inhibition lasts for much 
longer periods or possibly indefinitely. Such results may be explained 
by assuming that after a certain period of t:ilne the mechanisms con-
trolling estrus and ovulation become adapted to low inhibiting levels of 
the hormone and t hus operate in spite of continued treatment. Adaptation 
1~ 
to higher inhibitory levels, however, does not occur as soon if at all. 
Further investigation of these phenomena of adaptation is needed. 
If the effect of treatment were immediate no matings would be ex-
pected to occur for at least several days after the males were introduced. 
This is not the case in the experiments reported here. The lack of innne-
diate effect is very likely due to slow absorption of the progesterone 
into the circulation from the subcutaneous region. Investigation of the 
effects of intravenous administration which might be expected to have a 
more immediate effect should be carried out. 
The observati ons from records of vaginal smears and from histolog-
ical examination of ovaries reveal that the inhibition of mating by pro-
gesterone also involves an inhibition of estrus and ovulation. Treat-
ments intermediate in effect on the occurrence of mating usually result 
in partial estrus periods as indicated by only slight cornification of 
the vaginal epithelium. However, treatments with higher dosages which 
are maximum in effect cause a complete inhibition of all signs of estrus 
until mating occurs. After such treatments, smears similar to those of 
animals in dies t rus are found until the time of mating. Thus, at least 
in reference to signs of estrus, progesterone does not produce an tall 
or none' response. Histological examination of ovaries from treated 
animals show, in general, a lack of mature follicles, a. typical condition 
found in ovaries of animals in diestrus. A condition similar to that seen 
in animals in diestrus is also observed in the uterus. Thus, it is likely 
that the inhibition of estrus is closely associated with the inhibition 
of ovulation. Selye, ~ al (134) reported that 4.0 mg. of progesterone 
injected daily into rats produced diestrous smears within two days after 
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the first injection and that this condition persisted until the animals 
were kil led 12 days later. Autopsy revealed that no mature follicles 
were present in the ov~. The present investigation confirms this to 
an extent, but further shows that the same result can be obtained by 
treatments with as little as 2.0 to 5.0 mg. given twice weekly. 
Single injections of low doses of 5.0 mg. of progesterone given to 
females at various times after a successful mating have profound effects 
on subsequent developmental processes. If a single injection of 5.0 mg. 
is given before the males are introduced, mating is inhibited for an 
average of about 19 days, but once successful mating does occur preg-
nancy runs a normal course. Thus, when mating finally occurs, the 
existing inhibitory level of hormone must be sub-threshold in its effect 
on ovulation, fertilization, implantation and embryonic development. 
Although the experimental procedure employed in the present study 
could not distinguish between lack of fertili.zation and the degeneration 
of ova before implantation, it is likely that fertilization was at least 
partially inhibited since Boyarsky, et al (11) and Austin (178) found this 
t o be true after similar treatment with progesterone in the rabbit. An 
adverse effect on implantation was also noted supporting the findings of 
Burdick (86). The effect on 13 to 18 day old embryos was marked as 41.0 
percent of the embryos degenerated by the 21st d~. Thus, the reports 
of Symeonidis (311) and Karnofsky are confirmed. 
Anhydro-hydroxyprogesterone is an orally effective progestin which 
could conceivabl y inhibit ovulation . The experiments reported in this 
study show that oral administration of this compound has relatively 
little effect on mating and pregnancy in rats. The effec t on the delay 
lOS 
of mating is significant, but of very short duration (1 to 3 days). 
Furthermore, there is no apparent relation between dosage and effect. 
Administration qy injection has no effect whatsoever on the occurrence 
of mating indicating that anhydro-hydro.xyprogesterone ~ ~ might not 
possess the inhibiting properties noted with oral administration. Rather, 
the conflicting results of oral and injected administrations indicate that 
anhydro-hydroxyprogesterone might be converted, perhaps in the liver, to 
another compound which is the active inhibitor. Such a conversion has 
also been suggested by Henderson, ~ ~ (316) and Dorfman and Ungar (214). 
Binge (322) has shown that injection of anhydro-hydroxyprogesterone 
is effective progestationally, but the present study shows that such 
administration had no effect on the inhibition of estrus and ovulation. 
It is suggested, therefore, that compounds which are active progestationally 
are not necessarily inhibitors of es t rus and ovulation. 
The inhibition of mating which does occur with oral administration of 
aru1ydro-hydroxyprogesterone is reflected by the occurrence of only partial 
estrus periods. No dosage of this compound completely suppresses all 
signs of estrus. However, the treatments which inhibit mating, however 
slightly, cause an inhibition of follicular maturation and a condition in 
the uterus similar to that of diestrus. 
Contrary to the findings with progesterone, oral administration of 
17-methyl progesterone has no significant effects on mating, estrus, and 
ovulation. Since subcutaneous administration is very effective, it is 
suggested that an inactivation, perhaps by the l iver, might take place. 
Possibly this occurred in the case of orally administered progesterone. 
Injections of 17-methyl progesterone has a marked inhibitory effect 
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on the occurrence of estrus and mating. This effect is also of long 
duration, up to 40 or more days w:i th higher dosages. Furthermore single 
injections show distinct dose-response relationships with the maximum 
response occurring in the 10 to 25 mg. range. 
Although repeated injections of 2 mg. of 17-methyl progesterone 
prevent estrus and mating from occurring for relatively long periods, 
eventually, as in the case of progesterone successful mating and ovula-
tion do occur in spite of continued treatment. However, w.i.. th repeated 
injections of 5 mg., estrus and mating are delayed for much longer 
periods or possibly indefinitely. As in the case of repeated injections 
of progesterone, these results may be explained by assuming that an 
adaptation of mechanisms controlling estrus and ovulation occur when the 
inhibitory level is low at 2 mg. At higher levels of 5 mg. these mecha-
nisms are inhibited for much longer periods or indefinitely. 
Data from vaginal smears and microscopic examination of ovaries from 
animals treated with 17-methyl progesterone show that the inhibition of 
estrus is very closely associated with that of ovulation. Vaginal smears 
show that doses of 17-methyl progesterone intermediate in effect on the 
delay of mating result in the appearance of only partial estrous periods 
in which the vaginal epithelium becomes only partially cornified and the 
male is not accepted. However, the doses which are most effective cause 
complete inhibition of all signs of estrus. Diestrous smears are found 
until the time of mating. Examination of the ovaries from animals treated 
Ydth 17-rnethyl progesterone show a lack of mature follicles, a condition 
similar to that seen in ovaries of animals in diestrus. Examination of 
the uteri from the same animals show that the treatments had profound 
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effects on endometrial proliferation. 
Heusser, et !! (319) fol.Uld that i ?-methyl progesterone is twice as 
active progestationally as progesterone. However, the present study shows 
that this effect is not proportionally related to the degree of inhibi-
tion of estrus and ovulation. Although, at higher dosages 17-methyl 
progesterone is a more potent inhibitor than progesterone, at lower 
dosages this is not true. Therefore, it is once more indicated that 
progestational proliferation and estrus and ovulation are separately 
affected by administration of the hormone. 
Single injections of 5.0 mg. of 17-methyl progesterone given to 
females at various times after successful mating have profound effect 
on subsequent developmental processes. The results are like those found 
after similar treatments with progesterone and may be explained in the 
same manner • 
The results of the investigation reveal that none of the compounds 
tested are effective by oral administration. Since orally effective 
progestins are not necessarily effective inhibitors of estrus and ovu-
lation, it is suggested that further research may lead to the discovery 
of a compound which might inhibit ovulation without producing the usual 
side effects of progestins. 
If the results of these experiments are compared with those of 
Chang and Pincus (67) it can be seen that, in general, a species which 
ovulates spontaneously such as the rat responds to these compounds more 
or less in the same fashion as the rabbit which ovulate only after 
mating. 
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SUMMARY AND CONCLUSIONS 
1. Oral and subcutaneous administrations of various dosages of pro-
pylene glycol had no effect on estrus, mating, and pregnancy in rats. 
2. Single oral administrations of from 5 to 25 mg. of progesterone had 
slight, but statistically significant effects on mating, delaying its 
occurrence for from two to four days. 
3. Single injections of from 2 to 50 mg. of progesterone resulted in 
delay of mating for from three to nineteen days. 
With these treatments a clear dose-response relationship was noted 
with the maximum response occurring in the 2 to 10 mg. range. 
4. Injections of 2 and 5 mg. of progesterone twice weekly delayed mating 
for averages of 19 and 57 days respectively. 
The possibility of inhibiting mating indefinitely with repeated doses 
of 5 mg. of progesterone was indicated., while eventual .adaptation of 
the mechanisms controlling estrus and ovulation to the 2 mg. inhibi-
tory level was suggested. 
5. Differences in the effects of oral and injected administrations of 
progesterone indicate that an inactivation of the hormone, perhaps in 
the liver, takes place after oral treatment. 
6. Treatments with progesterone which were intermediate in effect on 
mating caused the occurrence of only partial estrous periods, while 
the most effective treatments completely inhibited estrus inducing 
a condition similar to diestrus. 
The inhibition of mating and es t rus also involved the inhibition of 
follicular maturation. 
7. No treatment with progesterone given before the males were introduced 
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to the females had any effect on subsequent reproductive processes 
once mating occurred. 
8. Single injections of 5 mg. of progesterone given at various times 
after successful mating had severely adverse effects on fertilization, 
implantation, and embryonic development after implantation. 
9. Single oral administrations of from 2 to 50 mg. of anhydro-hydroxy-
progesterone had slight, but statistically significant effects on 
mating, delaying its occurrence for from one to three days. 
10. Single injections of from 10 to 50 mg. of anhydro-hydroxypro gesterone 
were without effect. 
11. Differences in the effects of oral and injected administrations of 
a~1ydro-hydroxyprogesterone suggest that the compound per ~ does not 
inhibit mating, but rather that it is converted to an active compound 
when administered orally. 
12 • Trea.tments with anhydro-hydroxyprogesterone which were at all effec-
tive in inhibiting mating caused the occurrence of only partial 
estrous periods. 
No type of treatment completely suppressed estrus. 
The inhibition of mating by anhydro-hydroxyprogesterone also involved 
the inhibition of follicular maturation. 
13. No treatment w.i.. t h anhydro-hydroxprogesterone had any effect on sub-
sequent reproductive processes once mating occurred. 
14. Single oral administrations of from 2 to 50 mg. of 17-methyl pro-
gesterone were without effect on the occurrence of mating. 
15. Si ngle injections of from 5 to 50 mg. of 17- me thyl progesterone r e-
sulted in delay of mating for fro.m two to thirty-five dqys. 
lll 
16. Injections of 2 and 5 mg. of 17-methyl progesterone twice weekly 
delayed mating for averages of 19 and 61 days respectively. 
The possibility of inhibiting mating indefinitelywith repeated doses 
of 5 mg. was indicated, while eventual adaptation of the mechanisms 
cont rolling estrus and ovulation to the 2 mg. inhibitory level was 
suggested. 
17. Differences in the effects of oral and injected administrations of 
17-methyl progesterone indicate that an inactivation of the hormone, 
perhaps in the liver, takes place after oral treatment. 
18. Single intravaginal applications of from 2 to 10 mg. of 17-methyl 
progesterone was without effect. 
19. Treatments with 17-methyl progesterone which were intermediate in 
effect on mating caused the occurrence of only partial estrous periods, 
while the most effective treatments completely inhibited estrus and 
induced a condition similar to diestrus. 
The inhibition of mating and estrus also involved the inhibition of 
folli cular maturation. 
20. No treatment with 17-methyl progesterone given before the males wer e 
int roduced to the females had any effect on subsequent reproductive 
processes once mating occurred. 
21. Single injections of 5 mg. of 17-methyl progesterone given at various 
times after successful mating had severly adverse effects on ferti-
lization, implantation, and embryonic development. 
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PLATE 1 
Figure 1. Section of ova:ry from an untreated rat in diestrus. 
Note presence of immature and growing follicles, with absense 
of Graafian follicles. 
Figure 2. Section of uterus from an untreated rat in diestrus. 
Note lack of uterine distention. Note also the thickened 
endometrium and lack of glandular activity. 
Figure 3. Section of ova:ry from an untreated rat in early estrus. 
Note presence of normal numbers· of· immatuxe~ groWing and 
matured Graafian follicles . 
Figure 4. Section of uterus from an untreated rat in early estrus. 
Note distention of uterine lumen, increase of glandular 
activity and reduced thickness of endometrium. 
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PLATE 2 
Figure 5. Section of ovary from an untreated rat in estrus. 
Note presence of normal numbers of immature, growing, and 
matured Graafian follicles. 
• Figure 6. Section of uterus from an untreated rat in estrus. 
Note increased distension of uterine lumen, marked glandular 
activity and reduced thickness of endometrium. 
Figure 7. Section of ovary from a non-pregnant rat treated with a single 
injection of 50.0 mg. of progesterone 35 days previous to 
ld.lling. 
Note presence of normal numbers of innnature, growing, and 
matured Graafian follicles. 
Figure 8. Section of uterus from a non-pregnant rat treated with a single 
injection of 50.0 mg. of progesterone 35 days previous to 
ld.lling. 
Note lack of uterine distension. Note also the thickness and 
folds of the endometrium. 
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PLATE 3 
Figure 9. Section of the ova:ry from a non-pregnant rat treated with a 
single injection of 25 mg. of progesterone 35 days previous 
to killing. 
Note presence of immature an:i growing follicles, with absence 
of matured Graafian f ollicles. Compare with Figure 1. 
Figure 10. Section of uterus from a non-pregnant rat treated with a 
single injection of 25 mg. of progesterone 35 d~s previous 
to ldlling. 
Note marked thiclmess and folds of endometrium. 
Note also Jack of glandular activity. 
Figure 11. Section of ovary from a non-pregnant rat treated with a single 
oral dose of 50 mg. of anhydro-hydroxyprogesterone 29 days 
previous to killing. 
Note large numbers of immature, growing, and matured Graafian 
follicles. 
Figure 12. Section of uterus from a non-pregnant rat treated with a 
single oral dose of 50 mg. of anhydro-hydroxyprogesterone 29 
days previous to killing. 
Note thickness and folding of endometrium. 
Note also reduced glandular activity. 
PLATE 5 
Figure 17. Section of ova:ry from a non-pregnant rat treated with a single 
injection of 17-methyl proges t erone 47 days previous to killing. 
Note absence of matured Graafian follicles. 
Figure 18. Section of uterus from a non-pregnant rat treated with a single 
injection of 25 mg. of 17-methyl progesterone 47 days previous 
to killing. 
Note extremely small lumen and extreme thiclmess of endometrium. 
Note also reduced glandular activity. 
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Introduction. 
The reproductive process consists of a natural sequence o:f events 
each of which depends on delicate hormone, enzyme, dietary, and other 
physiological balances for successful completion. Slight alterations 
in these balances may prevent the reproductive process from going to 
completion. 
Although, in many of the reproductive events little is lmovm about 
the mechanisms llhich maintain these balances, there is sufficient 
information available about the hormone interreJ..a.tionships occurring 
during gamete production to warrant a study of their control. 
While the possibilities of hormonal control of spermatogenesis 
are evident, the many orderly timed relationships between estrogens, 
progesterone, and gonadotrophins make the female a more desirable 
subject. for the atudy of physiological balances. 
Since hypophyseal gonadotrophins are intimately involved in 
the process of ovUlation, the most desirable agent controlling this 
process is one which will inhibit gonadotrophic activity. At the 
present tiiOO, because if its natural ovulation-inhibiting action 
during the normal estrous cycle and pregnancy, progesterone is the 
most promising anti-gonadotrophic agent. 
Although the ovula.tion-irh~ibiting properties of progesterone 
and certain of its synthetic derivatives' have been well established 
in rabbits, no systematic investigation of nethods of administration, 
dosages, and side effects has been conducted in animals which ovulate 
spontaneous~. Therefore, it has been the purpose of this investigation 
to determine the ovulation-inhibiting effectiveness and, where possible, 
the side effects of various dosages and types of administration of proges-
terone and certain related compounds in the rat. 
Methods • 
. Sexu~ mature, virgin aJ.bino rats of the Sprague-Dawley strain were 
used. Each shipment of femaJ.es was screened for health and condition and 
six,...randomly chosen rats, each marked by ear puncture, were placed in each 
cage. Vaginal smears were taken dai:Qr for three or more days prior to the 
beginning or an experiment. 
The test compounds used ill the experiments consisted of a crystalline 
suspension of progesterone in saline, and crystalline preparations of 
17-methyl progesterone and anhydro-hydroxypro gesterone in propylene glycol •. 
These substances were administered either oraJ.ly, by subcutaneous injection, 
or intravagina.J.ly by means. of a pipette. Treatments consisted of either 
single, once weekly, or tw:i.ce weekly administrations. In no case were the 
males treated. 
Approximatezy 24 hours after the first treatment, two males of proved 
fertility were introduced into each cage of six females. Vaginal smears 
were taken daizy until the experiment was terminated. The males were 
changed weekl..v . 
The day during which a smear containing spermatozoa was found was 
'Considered as the day of mating. Twelve to · ifteen days after introduc-
tion of the males, the females were palpated and, when found pregnant, 
were killed. Mid-ventral laparotomies were performd and the n'lllTber of 
2. 
corpora lutea in the ovaries and of normal and, degenerated embryos 
in each uterus were recorded. Grown-rump lengths of the normal embryos 
were recorded so that in cases where no mating record was available the 
ages of the embryos and the dates of mating could be estimated by length 
comparisons with embryos of known age. In certain cases, ovaries and 
uteri were taken from animals which were not pregncmt when killed, and 
were prepared for histological examination. 
Control experiments. 
In general, no differences in the occurrence of estrus and mating, 
ovulation, fertilization and degeneration before implantation, and the 
development of embryos after implantation were noted between l.llltreated 
rats and rats treated with propylene glycol. 
EXperiments Yd. th progesterone. 
After mating occurred, no dosage or type of administration of 
progesterone had any effect on subsequent reproductive processes. 
Single oral administrations of from 5 to 2.5 mg. resulted in the delq 
of mating for two to four days beyond the longest delay in the control 
animals. This effect was slight, but statistica.lly significant. 
Single injections of from 2 to 50 mg., however, resulted in the delay 
of mating for as long as 19 days 1'f.i.. t h the highest dosages. Furthermore, 
a dose-response relationship was noted with the maximum response occurring 
in the range of 2 to 10 mg. 
Twice week:cy injections of 2: mg. of progesterone were as effective 
as a single injection of .50 mg. Since all animals in this group mated 
before the treatnvant was stopped, it is concluded that the mechanisms 
3 
controlling ovulation and estrus eventually become adapted to the Z mg. 
irlJrl.bit:ing level and function :in spite of cont:inued treatment. Twice 
weekly injections of 5 mg. were most effective and delayed estrus and 
mating for an average of approximately 57 days beyond the longest delay 
in the controls. Five of the eight animals in this group did not mate 
for from 6 to 58 days after treatment was stopped, indicating the possi-
bility of inhibiting mating for an indefinite period with continuous 
administration. This result suggests that at this higher inhibiting 
level the l!J3Chanisms controlling estrus and ovulation either do not 
adapt as readily as they do at lower levels or that they may be 
inhibited indefinitely. 
The relative ineffectiveness of ora~ administered progesterone 
as compared with administration by injection indicates that an inactiva-
tiolili of orally administered progesterone may take place~ perhaps in the 
liver. 
Data from records of vaginal smears showed tba:t dosages of proges-
terone intermediate in effect on the occurrence of mating did not 
completely inhibit periodic estrus. However, the most effective 
dosages did completely inhibit all signs: of estrus and produced 
diestrous smears, indicating that the effect of progesterone on the 
occurrence of estrus is not necessarily an •all or none• action. 
Histological examination of ovaries and uteri from non-pregnant 
animals treated with single injections of high dosages of progesterone 
four to five weeka previously showed that a condition similar to 
diestrus was produced, and this was confirmed by vaginal smears. 
No mature folicles were present in the wary, shavdng that the inhibition 
of mating and estrus was close~ associated with the inhibition of ovula-
tion. Progestational effects were also noted. 
Low dosages of 5 mg. of progesterone given by injection to animals 
at various times after mating had profound effects on subsequent develop-
mental processes. Injection immediate~ after mating resulted in either 
a partial failure of fertilization or in degeneration of the ova before 
implantation or both, involving a loss of 29.0 percent of the ovulated 
ova. Injection two days after mating resulted in failure of implanta-
tion of 33.0 percent of the ova. Injections given to animals which 
had been pregnant for l3 to 18 days resulted in the degeneration of 41.0 
percent of the embryos by the twenty-first day. 
Elcperiments with anhydro-hydro:xyprogesterone. 
No dosage or type of administration of anhydro-hydroxyprogesterone 
had any effect on subsequent reproductive processes after mating occurred. 
Single oral administrations of from 2 to 50 mg. had significant effects on 
the delay of mating, but these effects were s]j.ght and of short duration 
(1 to 3 days). No apparent relation between dosage and effect occurred. 
Administration of from 10 to 50 mg. by single injections had no effect, 
indicating that anhydro-bydroxyprogesterone ~~may not be an inhibitor 
of estrus and ovulation, but, rather, may be converted in the body to 
another compound which is active in inhibiting estrus and ovulation. 
Vaginal s:rooars showed that oral administration which had slight 
inhibitory action on the occurrence of mating resulted in only partiaJ. 
estrous periods. wo dosage completely inhibited estrus. 
Histological examination of ovaries and uteri revealed that 
treatments which were effective in inhibiting mating also inhibited 
follicular maturation and induced a condition similar to that of 
diestrus. Progestational effects were also noted. 
Experiments with 17-methyl progesteron~. 
fuce mating occurred, no dosage or type of administration of 
17-methyl progesterone had any effect on subsequent reproductive 
processes. Contrary to the findings with progesterone, oral 
administration had no significant effect on mating, estrus, or 
ovulation. Since subcutaneous administration was very effective, 
it is suggested that an inactivation, perhaps by the liver, occurs 
when 17-methyl progesterone is administered orally. Single injections 
of from 5 to 50 mg. had marked inhibiting effects, the highest dosages 
delaying mating for 35 dczy's or more beyond the longest delay in the 
control animals. Furthermore, a definite dose-response relationship 
occurred with the maximum response occurring in the range of 10 to 25 mg. 
TWice weekly injections of 2 and 5 mg. of 17-nethyl progesterone 
produced results very similar to those produced by the same types of 
treatment with progesterone, delaying mating for 19 and 61 da\vs 
respectively beyond the longest del~ in the control gr:-oups . As in 
the case of progesterone, adaptation of the mechanisms controlling 
estr.us and ovulation occurred at the a mg. inhibiting level, but not 
at the 5 mg. level. Intravaginal applications of .f'rom Z to 10 mg. 
of 17-methyl progesterone w:ere without significant effect. 
6. 
Vaginal. smears showed that treatments intermediate in eff'ect 
caused the occurrence of only partiaJ. estrous periods while treat-
ments that were most ef'fective completely inhibited all signs of 
estrus and produced diestrous smears. 
Histological examination of the ovaries and uteri .from non-
pregnant animals treated with single injections of high dosages of 
17-methyl progesterone two to three weeks previously reveaJ.ed a 
condition similar to that of diestrus. No mature follicles were 
present, but the progestational effects were marked. 
Results of experiments in which single injections of 5 mg. 
were given to animals in various stages of pregnancy were similar 
to those in the corresponding experiments with progesterone. 
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